學術研究成果/Publication
基本資料/Profiles
姓名/Name: 顏宏融 性別/Gender:
英文姓名/
English Name:
Hung-Rong Yen 英文縮寫/
Abbreviation:
任職單位/
Affiliation:
1.中醫學院中醫學系學士班中醫婦兒學科(教授) / (Professor)
2.中國附醫中西醫結合科(科(室)主任) / Department of Integration of Traditional Chinese and Western Medicine (Director)
Email: hungrongyen@mail.cmu.edu.tw
研究專長/Fields of Specialty
1﹒ 中醫藥轉譯研究 / TCM Translational Study
2﹒ 免疫學 / Immunology
3﹒ 中醫兒科 / TCM Pediatrics
4﹒ 整合醫學 / Integrative Medicine
 
期刊論文/Journal Paper
(作者群,論文題目,期刊名稱,出版年月,卷號(期別):頁次起迄)
SCI論文 黃明正(Ming-Cheng Huang)、顏宏融(Hung-Rong Yen)、林橙莉(Cheng-Li Lin)、李育臣(Yu-Chen Lee)、孫茂峰(Mao-Feng Sun)*、吳美瑤(Mei-Yao Wu)*,Acupuncture decreased the risk of stroke among patients with fibromyalgia in Taiwan: A nationwide matched cohort study,PLoS One,2020 Oct,15(10):
SCI論文 Gil Ton(Gil Ton)、(Yu-Cih Yang)、李俐雯(Li-Wen Lee)、何文照、陳易宏、顏宏融(Hung-Rong Yen)、李育臣(Yu-Chen Lee)*,Acupuncture Decreased the Risk of Coronary Heart Disease in Patients with Osteoarthritis in Taiwan:A Nationwide Matched Cohort Study,JOURNAL OF ALTERNATIVE AND COMPLEMENTARY MEDICINE,2020 Jul,00(00):1-11
SCI論文 李家琳(Chia-Lin Lee)*、王建旻、郭悅雄(Yueh-Hsiung Kuo)、顏宏融(Hung-Rong Yen)、宋瑛琪(Ying-Chyi Song)、(Yu-Lun Chou)、陳朝榮(Chao-Jung Chen),IL-17A inhibitions of indole alkaloids from traditional Chinese medicine Qing Dai,JOURNAL OF ETHNOPHARMACOLOGY,2020 Jun,255():112772-112772
SCI論文 (Kai-Li Liang)、(Sheng-Jie Yu)、(Wan-Chun Huang)、顏宏融(Hung-Rong Yen)*,Luteolin Attenuates Allergic Nasal Inflammation via Inhibition of Interleukin-4 in an Allergic Rhinitis Mouse Model and Peripheral Blood From Human Subjects With Allergic Rhinitis,Frontiers in Pharmacology,2020 Mar,11():291
SCI論文 (Jiani Wang)、(Alize A Rogge)、(Mike Armour)、(Caroline A Smith)、(Christopher R D’Adamo)、(Claudia R Pischke)、顏宏融(Hung-Rong Yen)、吳美瑤(Mei-Yao Wu)、(Ari Ojeda Ocampo More)、(Claudia M Witt)*、(Daniel Pach)*,International ResearchKit App for Women with Menstrual Pain: Development, Access, and Engagement,JMIR mHealth and uHealth,2020 Feb,8(2):e14661
SCI論文 蔡淯淇(Tsai Yu-Chi)、李家琳(Chia-Lin Lee)、顏宏融(Hung-Rong Yen)、(Young-Sheng Chang)、(Yu-Ping Lin)、(Su-Hua Huang)、林振文(Lin Cheng Wen)*,Antiviral Action of Tryptanthrin Isolated from Strobilanthes cusia Leaf against Human Coronavirus NL63,Biomolecules,2020 Feb,10(3):E366
SCI論文 宋瑛琪(Ying-Chyi Song)、黃慧琪(Hui-Chi Huang)、張穎宜(Yin-Yi Chang)、李蕙汝(Hui-Ju Lee)、劉傳騰、羅欣宜(Lo, Hsin-Yi)、侯庭鏞、林武周(Wu-Chou Lin)、顏宏融(Hung-Rong Yen)*,A Potential Herbal Adjuvant Combined With a Peptide-Based Vaccine Acts Against HPV-Related Tumors Through Enhancing Effector and Memory T-Cell Immune Responses,Frontiers in Immunology,2020 Feb,11():62
SCI論文 許游章(You-Cheng Hseu)、(Xuan-Zao Chen)、(Yugandhar Vudhya Gowrisankar)、顏宏融(Hung-Rong Yen)、莊淨媛、楊新玲(Hsin-Ling Yang)*,The Skin-Whitening Effects of Ectoine via the Suppression of α-MSH-Stimulated Melanogenesis and the Activation of Antioxidant Nrf2 Pathways in UVA-Irradiated Keratinocytes,Antioxidants,2020 Jan,9(63):1-15
SCI論文 王婕(Wang chieh)、李育臣(Yu-Chen Lee)、吳美瑤(Mei-Yao Wu)、林橙莉(Cheng-Li Lin)、孫茂峰(Mao-Feng Sun)、林昭庚(Jaung-Geng Lin)、顏宏融(Hung-Rong Yen)*,Trends in the Utilization of Acupuncture among Children in Taiwan from 2002 to 2011: A Nationwide Population-Based Study,BMC Complementary and Alternative Medicine,2019 Nov,19():328
SCI論文 許游章(You-Cheng Hseu)、(Chih-Ting Chang)、(Yugandhar Vudhya Gowrisankar)、(Xuan-Zao Chen)、林煇章(Hui-Chang Lin)、顏宏融(Hung-Rong Yen)*、楊新玲(Hsin-Ling Yang)*,Zerumbone Exhibits Antiphotoaging and Dermatoprotective Properties in Ultraviolet A-Irradiated Human Skin Fibroblast Cells via the Activation of Nrf2/ARE Defensive Pathway,Oxidative Medicine and Cellular Longevity,2019 Nov,2019(-):1-14
SCI論文 (Wan-Ting Liao)、(Cheng-Chiung Su)、(Ming-Tsung Lee)、(Chia-Jung Li)、林橙莉(Cheng-Li Lin)、(Jen-Huai Chiang)、顏宏融(Hung-Rong Yen)*,Integrative Chinese herbal medicine therapy reduced the risk of type 2 diabetes mellitus in patients with polycystic ovary syndrome: A nationwide matched cohort study,JOURNAL OF ETHNOPHARMACOLOGY,2019 Oct,243():112091
SCI論文 宋瑛琪(Ying-Chyi Song)、洪國?(Kuo-Feng Hung)、梁凱莉(Kai-Li Liang)、(Jen-Huai Chiang)、黃慧琪(Hui-Chi Huang)、李蕙汝(Li, Hui-Ju)、吳美瑤(Mei-Yao Wu)、游勝傑(Sheng-Jie Yu)、羅欣宜(Lo, Hsin-Yi)、侯庭鏞、顏宏融(Hung-Rong Yen)*,Adjunctive Chinese herbal medicine therapy for nasopharyngeal carcinoma: Clinical evidence and experimental validation,HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK,2019 Sep,41(9):2860-2872
SCI論文 黃升騰(Sheng-Teng Huang)*、許偉帆(Wei-Fan Hsu)、黃紘森(Huang Hung-Sen)、顏加豪(Jia-hau Yen)、林美辰(Mei-Chen Lin)、彭成元(Cheng-Yuan Peng)、顏宏融(Hung-Rong Yen)*,Improved Survival in Hepatocellular Carcinoma Patients with Cardiac Arrhythmia by Amiodarone Treatment through Autophagy,INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES,2019 Aug,20(16):3978
SCI論文 李家琳(Chia-Lin Lee)*、(Chien-Ming Wang)、(Hao-Chun Hu)、顏宏融(Hung-Rong Yen)、宋瑛琪(Ying-Chyi Song)、游勝傑(Sheng-Jie Yu)、陳朝榮(Chao-Jung Chen)、(Wei-Chu Li)、吳永昌(Yang-Chang Wu)*,Indole alkaloids indigodoles A–C from aerial parts of Strobilanthes cusia in the traditional Chinese medicine Qing Dai have anti-IL-17 properties,PHYTOCHEMISTRY,2019 Jun,162():39-46
SCI論文 許游章(You-Cheng Hseu)、(Yi-Geng Ho)、(Dony Chacko Mathew)、顏宏融(Hung-Rong Yen)、(Xuan-Zao Chen)、楊新玲(Hsin-Ling Yang)*,The in vitro and in vivo depigmenting activity of Coenzyme Q10 through the down-regulation of α-MSH signaling pathways and induction of Nrf2/AREmediated antioxidant genes in UVA-irradiated skin keratinocytes,BIOCHEMICAL PHARMACOLOGY,2019 Jun,164():299-310
SCI論文 陳亮宇(Liang-Yu Chen)、顏宏融(Hung-Rong Yen)、孫茂峰(Mao-Feng Sun)、林橙莉(Cheng-Li Lin)、(Jen-Huai Chiang)、李育臣(Yu-Chen Lee)*,Acupuncture treatment is associated with a decreased risk of developing stroke in patients with depression: A propensity-score matched cohort study,JOURNAL OF AFFECTIVE DISORDERS,2019 Mar,250():298-306
SCI論文 (Wen-Chieh Liao)、顏宏融(Hung-Rong Yen)、(Chih-Kai Liao)、(To-Jung Tseng)、(Chyn-Tair Lan)、(Chiung-Hui Liu)*,DSE regulates the malignant characters of hepatocellular carcinoma cells by modulating CCL5/CCR1 axis,American Journal of Cancer Research,2019 Feb,9(2):347-362
SCI論文 吳美瑤(Mei-Yao Wu)、黃明正(Ming-Cheng Huang)、廖厚勳(Hou-Hsun Liao)、蔣仁槐(Jen-Huai Chiang)、李育臣(Yu-Chen Lee)、許重義(Chung Y. Hsu)、孫茂峰(Mao-Feng Sun)*、顏宏融(Hung-Rong Yen)*,Acupuncture decreased the risk of coronary heart disease in patients with rheumatoid arthritis in Taiwan: a Nationwide propensity score-matched study,BMC Complementary and Alternative Medicine,2018 Dec,18():341-351
SCI論文 (Kuan-Yu Chen)、吳美瑤(Mei-Yao Wu)、楊佩珊(Yang pei shan)、(Jen-Huai Chiang)、許重義(Chung Y. Hsu)、陳秋瑩(Chen, Chiu-Ying)*、顏宏融(Hung-Rong Yen)*,Utilization of Chinese Herbal Medicine and its Association with the Risk of Fracture in Patients with Parkinson’s Disease in Taiwan,JOURNAL OF ETHNOPHARMACOLOGY,2018 Nov,226():168-175
SCI論文 楊仕哲(Su-Tso Yang)*、林邑蓉(Yi-Rong Lin)、吳美瑤(Mei-Yao Wu)、(Jen-Huai Chiang)、楊佩珊(Yang pei shan)、夏德椿(Te-Chun Hsia)、顏宏融(Hung-Rong Yen)*,Utilization of Chinese Medicine for Respiratory Discomforts by Patients with a Medical History of Tuberculosis in Taiwan,BMC Complementary and Alternative Medicine,2018 Nov,18(1):313
SCI論文 馮堂正(Tom Fleischer)、張東廸(Chang, Tung-Ti)、蔣仁槐(Chiang, Jen-Huai)、顏宏融(Yen, Hung-Rong)*,A Controlled Trial of Sheng-Yu-Tang for Post-Hematopoietic Stem Cell Transplantation Leukemia Patients: A Proposed Protocol and Insights From a Preliminary Pilot Study,INTEGRATIVE CANCER THERAPIES,2018 Sep,17(3):665-673
SCI論文 賴慶元(Lai, Ching-Yuan)、(Jen-Huan Chiang)、林昭庚(Jaung-Geng Lin)、顏宏融(Hung-Rong Yen)、杜政昊(Tu, Cheng-Hao)*、陳易宏*,Chinese herbal medicine reduced the risk of stroke in patients with Parkinson’s disease: A population-based retrospective cohort study from Taiwan,PLoS One,2018 Sep,13(9):
Other論文 謝宜庭(Yi-Ting Hsieh)、賴香君(Hsiang-Chun Lai)、歐世宸(Ou Shi Chen)、顏宏融(Hung-Rong Yen)、沈俐伶(Li Ling Shen),中西醫結合治療早期破水胎動不安之病例報告(下),台中市中醫會刊,2018 Aug,(115):9-20
SCI論文 廖婉婷、(Jen-Huai Chiang)、(Chia-Jung Li)、(Ming-Tsung Lee)、(Cheng-Chiung Su)、顏宏融(Hung-Rong Yen)*,Investigation on the Use of Traditional Chinese Medicine for Polycystic Ovary Syndrome in a Nationwide Prescription Database in Taiwan,Journal of Clinical Medicine,2018 Jul,7(7):179
SCI論文 郭怡婷(Yi-Ting Kuo)、廖厚勳(Hou-Hsun Liao)、蔣仁槐(Chiang, Jen-Huai)、(Bor-Chyuan Chen)、(Ching-Mao Chang)、葉明憲、張東廸(Tung-Ti Chang)、孫茂峰(SUN, MAO-FENG)、葉家舟*、顏宏融(Hung-Rong Yen)*,Complementary Chinese Herbal Medicine Therapy Improves Survival of Patients with Pancreatic Cancer in Taiwan: A Nationwide Population-Based Cohort Study,INTEGRATIVE CANCER THERAPIES,2018 Jun,17(2):411-422
SCI論文 郭怡婷(Yi-Ting Kuo)、張東廸(Tung-Ti Chang)、(Chih-Hsin Muo)、吳美瑤(Mei-Yao Wu)、孫茂峰(SUN, MAO-FENG)、葉家舟*、顏宏融(Hung-Rong Yen)*,Use of Complementary Traditional Chinese Medicines by Adult Cancer Patients in Taiwan: A Nationwide Population-based Study,INTEGRATIVE CANCER THERAPIES,2018 Jun,17(2):531-541
Other論文 謝宜庭(Yi-Ting Hsieh)、賴香君(Hsiang-Chun Lai)、歐世宸(Ou Shi Chen)、顏宏融(Hung-Rong Yen)、沈俐伶(Li Ling Shen),中西醫結合治療早期破水胎動不安之病例報告(上),台中市中醫會刊,2018 Jun,(114):33-36
SCI論文 (Lin-Lin Chen)、(Yuntao Dai)、(Robert Verpoorte)、顏宏融(Yen, Hung-Rong)、彭文煌(Peng, Wen-Huang)、鄭永齊(Yung-Chi Cheng)、趙嶸(Chao, Jung)*、鮑力恒(Li-Heng Pao)*,Effects of processing adjuvants on traditional Chinese herbs,JOURNAL OF FOOD AND DRUG ANALYSIS,2018 Apr,26(2S):S96-S114
SCI論文 吳美瑤(Mei-Yao Wu)、李育臣(Lee, Yu-Chen)、林橙莉、黃明正(Ming-cheng Huang)、孫茂峰(Sun, Mao-Feng)、顏宏融(Yen, Hung-Rong)*,Trends in use of acupuncture among adults in Taiwan from 2002 to 2011: A nationwide population-based study,PLoS One,2018 Apr,13(4):e0195490-e0195499
SCI論文 邱正迪(Chiu, Cheng-Di)、(Hsuan-Ju Chen)、(Hean-Pat Saw)、(Nai-Wei Yao)、顏宏融(Yen, Hung-Rong)、高嘉鴻(Kao, Chia-Hung)*,Asthma and early herniated intervertebral disc disease,CURRENT MEDICAL RESEARCH AND OPINION,2017 Nov,33(11):2019-2025
SCI論文 林怡君(Yi-Chun Lin)、林知瑩(Lin, Chih-Ying)、謝秀盈(Siew-Yin Chee)、顏宏融(Yen, Hung-Rong)、蔡輔仁(Tsai, Fuu-Jen)、陳秋瑩(Chen, Chiu-Ying)*、王仲興(Chung-Hsing Wang)*,Improved final predicted height with the injection of leuprolide in children with earlier puberty: A retrospective cohort study,PLoS One,2017 Oct,12(10):e0185080
SCI論文 黃國欽(Huang, kuo-Chin)、顏宏融(Yen, Hung-Rong)、蔣仁槐(Chiang, Jen-Huai)、(Yuan-Chih Su)、孫茂峰(Sun, Mao-Feng)、張恒鴻(Chang, Hen-Hong)、黃升騰(Huang, Sheng-Teng)*,Chinese Herbal Medicine as an Adjunctive Therapy Ameliorated the Incidence of Chronic Hepatitis in Patients with Breast Cancer: A Nationwide Population-Based Cohort Study,Evidence-based Complementary and Alternative Medicine,2017 Oct,2017(2017):1-9
SCI論文 賴慶元(ChingYuan Lai)、吳美瑤(Mei-Yao Wu)、蔣仁槐(Chiang, Jen-Huai)、孫茂峰(SUN, MAO-FENG)、陳易宏(Yi-Hung Chen)、張志宗(Chiz-Tzung Chang)、林昭庚(Jaung-Geng Lin)*、顏宏融(Hung-Rong Yen)*,Utilization of Western medicine and traditional Chinese medicine among patients with Alzheimer’s disease in Taiwan: a nationwide population-based study,EUROPEAN JOURNAL OF NEUROLOGY,2017 Sep,24(9):1166-1172
SCI論文 (Angela Shin-Yu Lien)、(Jia-Ling Tsai)、(Jian-Tao Lee)、吳美瑤(Mei-Yao Wu)、(Yi-Der Jiang)*、顏宏融(Hung-Rong Yen)*,A Systematic Review and Meta-Analysis of the Effect of Lifestyle Modification on Metabolic Control in Overweight Children,Evidence-based Complementary and Alternative Medicine,2017 Sep,2017():5681909
SCI論文 林邑蓉(Yi-Rong Lin)、吳美瑤(Mei-Yao Wu)、蔣仁槐(Chiang, Jen-Huai)、顏宏融(Yen, Hung-Rong)*、楊仕哲(Yang, Su-Tso (Yang, Shi-zhe))*,The utilization of traditional Chinese medicine in patients with dysfunctional uterine bleeding in Taiwan: A nationwide population-based study,BMC Complementary and Alternative Medicine,2017 Aug,17(1):427
SCI論文 顏宏融(Hung-Rong Yen)*、賴琬郁(Wan-Yu Lai)、莫之欣、孫茂峰(SUN, MAO-FENG),Characteristics of Traditional Chinese Medicine Use in Pediatric Cancer Patients: A Nationwide, Retrospective, Taiwanese-Registry, Population-Based Study,INTEGRATIVE CANCER THERAPIES,2017 Jun,16(2):147-155
SCI論文 馮堂正(Tom Fleischer)、張東廸(Tung-Ti Chang)、蔣仁槐(Chiang, Jen-Huai)、孫茂峰(SUN, MAO-FENG)、顏宏融(Hung-Rong Yen)*,Improved Survival With Integration of Chinese Herbal Medicine Therapy in Patients With Acute Myeloid Leukemia: A Nationwide Population-Based Cohort Study,INTEGRATIVE CANCER THERAPIES,2017 Jun,16(2):156-164
Other論文 林怡君(Yi-Chun Lin)、吳旻峰(Min-Feng Wu)、蔡邱轔(Chiu-Lin Tsai)、張東廸(Tung-Ti Chang)、顏宏融(Hung-Rong Yen)*,臍療治療小兒厭食:1994−2014年中國期刊文獻分析(Navel Herbal Plaster Therapy for the Treatment of Children with Poor Appetite: Analysis of Chinese Literatures from 1994 to 2014),中醫藥雜誌,2017 Jun,28(1):
SCI論文 林怡君(Yi-Chun Lin)、張東廸(Tung-Ti Chang)、陳宣如(Chen, Hsuan-Ju)、王仲興(Chung-Hsing Wang)、孫茂峰(SUN, MAO-FENG)、顏宏融(Hung-Rong Yen)*,Characteristics of Traditional Chinese Medicine Usage in Children with Precocious Puberty: A Nationwide Population-Based Study,JOURNAL OF ETHNOPHARMACOLOGY,2017 Jun,205():231-239
SSCI論文 (Jiun-Nong Lin)、林橙莉、顏宏融(Hung-Rong Yen)、(Chi-Hui Yang)、(Chung-Hsu Lai)、(Hsi-Hsun Lin)、高嘉鴻(Chia-Hung Kao)*,Increased Risk of Tics in Children Infected with Enterovirus: A Nationwide Population-Based Study,JOURNAL OF DEVELOPMENTAL AND BEHAVIORAL PEDIATRICS,2017 May,38(4):276-282
SCI論文 林彩蕙(Tsai-Hui Lin)、顏宏融(Hung-Rong Yen)、蔣仁槐(Chiang, Jen-Huai)、孫茂峰(SUN, MAO-FENG)、張恒鴻(CHANG,HEN-HONG)、黃升騰(Huang, Sheng-Teng)*,The use of Chinese herbal medicine as an adjuvant therapy to reduce incidence of chronic hepatitis in colon cancer patients: A Taiwanese population-based cohort study,JOURNAL OF ETHNOPHARMACOLOGY,2017 Apr,202():225-233
SCI論文 洪國(Kuo-Feng Hung)、(Ching-Ping Hsu)、蔣仁槐(Chiang, Jen-Huai)、林宏任(Lin Hung-jen)、郭怡婷(Yi-Ting Kuo)、孫茂峰(SUN, MAO-FENG)、顏宏融(Hung-Rong Yen)*,Complementary Chinese Herbal Medicine Therapy Improves Survival of Patients with Gastric Cancer in Taiwan: A Nationwide Retrospective Matched-Cohort Study,JOURNAL OF ETHNOPHARMACOLOGY,2017 Mar,199():168-174
SCI論文 廖厚勳(Hou-Hsun Liao)、顏宏融(Hung-Rong Yen)、(Chih-Hsin Muo)、李育臣(Yu-Chen Lee)、吳美瑤(Mei-Yao Wu)、周立偉(Li-Wei Chou)、孫茂峰(SUN, MAO-FENG)、張東廸(Tung-Ti Chang)*,Complementary traditional Chinese medicine use in Children with cerebral palsy: a nationwide retrospective cohort study in Taiwan,BMC Complementary and Alternative Medicine,2017 Mar,17():115
SCI論文 廖元敬(Yuan-Ching Liao)、周哲毅(Che-Yi Chou)、張志宗(Chiz-Tzung Chang)、李采娟(Tsai-Chung Li)、孫茂峰(SUN, MAO-FENG)、張恒鴻(CHANG,HEN-HONG)、蔡輔仁(Fuu-Jen Tsai)、顏宏融(Hung-Rong Yen)*,Qi deficiency is associated with depression in chronic hemodialysis patients,COMPLEMENTARY THERAPIES IN MEDICINE,2017 Feb,30():102-106
SCI論文 賴佳汶(Jia-Wen Lai)、陳虹志(Hung-Chih Chen)、周哲毅(Che-Yi Chou)、顏宏融(Hung-Rong Yen)、李采娟(Tsai-Chung Li)、孫茂峰(SUN, MAO-FENG)、張恒鴻(CHANG,HEN-HONG)、黃秋錦(Chiu-Ching Huang)、蔡輔仁(Fuu-Jen Tsai)、(Johannes Tschen)、張志宗(Chiz-Tzung Chang)*,Transformation of 5-D itch scale and numerical rating scale in chronic hemodialysis patients,BMC Nephrology,2017 Feb,18(56):
SCI論文 吳美瑤(Mei-Yao Wu)、黃明正(Ming-cheng Huang)、蔣仁槐(Chiang, Jen-Huai)、孫茂峰(SUN, MAO-FENG)、李育臣(Yu-Chen Lee)*、顏宏融(Hung-Rong Yen)*,Acupuncture decreased the risk of coronary heart disease in patients with fibromyalgia in Taiwan: a nationwide matched cohort study,ARTHRITIS RESEARCH & THERAPY,2017 Feb,19():37
SCI論文 (Ching-Mao Chang)、吳柏樟(Po-Chang Wu)、蔣仁槐(Chiang, Jen-Huai)、(Yau-Huei Wei)、(Fang-Pey Chen)、(Tzeng-Ji Chen)、(Tai-Long Pan)、顏宏融(Hung-Rong Yen)*、張恒鴻(CHANG,HEN-HONG)*,Integrative Therapy Decreases the Risk of Lupus Nephritis in Patients with Systemic Lupus Erythematosus: A Population-Based Retrospective Cohort Study,JOURNAL OF ETHNOPHARMACOLOGY,2017 Jan,196():201-212
SCI論文 (Chia-Yu Liu)、(Jui-Ying Chu)、(Jen-Huai Chiang)、顏宏融(Hung-Rong Yen)*、許中華(Chung-Hua Hsu)*,Utilization and prescription patterns of traditional Chinese medicine for patients with hepatitis C in Taiwan: a populationbased study,BMC Complementary and Alternative Medicine,2016 Oct,16(1):397
SCI論文 (Angela Shin-Yu Lien)、(Yi-Der Jiang)、莫之欣、孫茂峰(SUN, MAO-FENG)、(Bih-Shya Gau)*、顏宏融(Hung-Rong Yen)*,Integrative traditional Chinese medicine therapy reduces the risk of diabetic ketoacidosis in patients with type 1 diabetes mellitus,JOURNAL OF ETHNOPHARMACOLOGY,2016 Sep,191():324-330
SCI論文 翁淑雯(Weng, Shu-Wen)、(Bor-Chyuan Chen)、王昱喬(Wang Yu Chiao)、劉俊凱(Liu Chun Kai)、孫茂峰(SUN, MAO-FENG)、(Ching-Mao Chang)、林昭庚(Jaung-Geng Lin)*、顏宏融(Hung-Rong Yen)*,Traditional Chinese Medicine Use among Patients with Psoriasis in Taiwan: A Nationwide Population-based Study,Evidence-based Complementary and Alternative Medicine,2016 Sep,2016():3164105
SCI論文 (Chia-Yu Liu)、(Pin-Hao Ko)、顏宏融(Hung-Rong Yen)、(Chen-Hung Cheng)、(Yu-Hsien Li)、(Zih-Han Liao)、許中華(Chung-Hua Hsu)*,The Chinese medicine Kuan-Sin-Yin improves liver function in patients with chronic hepatitis C: A randomised and placebo-controlled trial,COMPLEMENTARY THERAPIES IN MEDICINE,2016 Aug,27():114-122
SCI論文 張家綺(Chia-Chi Chang)、李育臣(Yu-Chen Lee)、林則成(Lin, Che-Chen)、(Chin-Hsien Chang)、邱正迪(Cheng-Di Chiu)、周立偉(Li-Wei Chou)、孫茂峰(SUN, MAO-FENG)、顏宏融(Hung-Rong Yen)*,Characteristics of traditional Chinese medicine usage in patients with stroke in Taiwan: A nationwide population-based study,JOURNAL OF ETHNOPHARMACOLOGY,2016 Jun,186():311-321
SCI論文 張恆偉(Heng-Wei Chang)、鄭慧滿(Hui-Man Cheng)、顏宏融(Hung-Rong Yen)、許重義(Chung Y. Hsu)、李育臣(Yu-Chen Lee)、(Jen-Huai Chiang)、孫茂峰(SUN, MAO-FENG)*,Association between chronic idiopathic urticaria and hypertension : A population-based retrospective cohort study,ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY,2016 Jun,116(06):554-558
SCI論文 馮堂正(Tom Fleischer)、張東廸(Tung-Ti Chang)、蔣仁槐(Chiang, Jen-Huai)、謝清昀(Ching-Yun Hsieh)、孫茂峰(SUN, MAO-FENG)、顏宏融(Hung-Rong Yen)*,Integration of Chinese Herbal Medicine Therapy Improves Survival of Patients With Chronic Lymphocytic Leukemia: A Nationwide Population-Based Cohort Study,MEDICINE,2016 May,95(21):e3788
SCI論文 馮堂正(Tom Fleischer)、張東廸(Tung-Ti Chang)、(Jen-Huai Chiang)、(Ching-Mao Chang)、謝清昀(Ching-Yun Hsieh)、顏宏融(Hung-Rong Yen)*,Adjunctive Chinese Herbal Medicine therapy improves survival of patients with chronic myeloid leukemia: a nationwide population-based cohort study,Cancer Medicine,2016 Apr,5(4):640-648
SCI論文 李艾玲(Ai-Lin Lee)、(Bor-Chyuan Chen)、莫之欣、孫茂峰(SUN, MAO-FENG)、顏宏融(Hung-Rong Yen)*,Association of Traditional Chinese Medicine Therapy and the Risk of Vascular Complications in Patients With Type II Diabetes Mellitus: A Nationwide, Retrospective, Taiwanese-Registry, Cohort Study,MEDICINE,2016 Jan,95(3):e2536
SCI論文 (Ting-Ting Yen)、(Ching-Heng Lin)、(Rong-San Jiang)、(Yi-Ting Shih)、顏宏融(Hung-Rong Yen)*、(Kai-Li Liang)*,Incidence of Late-onset Pneumonia in Patients after Treatment with Radiotherapy for Nasopharyngeal Carcinoma: A Nationwide Population-based Study,HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK,2015 Dec,37(12):1756-1761
SCI論文 黃明正(Ming-cheng Huang)、(Fu-Tzu Pai)、林則成(Lin, Che-Chen)、(Ching-Mao Chang)、張恒鴻(CHANG,HEN-HONG)、李育臣(Yu-Chen Lee)、孫茂峰(SUN, MAO-FENG)、顏宏融(Hung-Rong Yen)*,Characteristics of Traditional Chinese Medicine Use in Patients with Rheumatoid Arthritis in Taiwan: A Nationwide Population-Based Study,JOURNAL OF ETHNOPHARMACOLOGY,2015 Dec,176():9-16
SCI論文 黃靜瑩(Chin-Ying Huang)、賴琬郁(Wan-Yu Lai)、孫茂峰(SUN, MAO-FENG)、林則成(Lin, Che-Chen)、(Bor-Chyuan Chen)、林宏任(Lin Hung-jen)、(Ching-Mao Chang)、楊中賢(Chung-Hsion Yang)、黃國欽(kuo-Chin Huang)、顏宏融(Hung-Rong Yen)*,Prescription Patterns of Traditional Chinese Medicine for Peptic Ulcer Disease in Taiwan: A Nationwide Population-based Study,JOURNAL OF ETHNOPHARMACOLOGY,2015 Dec,176():311-320
SCI論文 顏宏融(Hung-Rong Yen)、(Yueh-Chiao Yeh)、(Rong-San Jiang)、(Ren-Ching Wang)、(Wan-Chun Huang)、(Shyh-Chang Chen)、林伯修(Bo-Shiou Lin)、(Kai-Li Liang)*,Dose-response relationship of specific allergen exposure-induced immunological tolerance: a mouse model,International Forum of Allergy & Rhinology,2015 Sep,5(9):784-793
SCI論文 廖厚勳(Hou-Hsun Liao)、(Chia-Chou Yeh)、林則成、(Bor-Chyuan Chen)、(Ming-Hsien Yeh)、張國銘(Kuo-Ming Chang)、孫茂峰(SUN, MAO-FENG)*、顏宏融(Hung-Rong Yen)*,Prescription Patterns of Chinese herbal products for Patients with Fractures in Taiwan: A nationwide population-based study,JOURNAL OF ETHNOPHARMACOLOGY,2015 Sep,173():11-19
SCI論文 顏宏融(Hung-Rong Yen)、陳盈佑(Ying-Yu Chen)、(Tzu-Ping Huang)、張東廸(Tung-Ti Chang)、曹榮穎(Jung-Ying Tsao)、(Bor-Chyuan Chen)、孫茂峰(SUN, MAO-FENG)*,Prescription Patterns of Chinese Herbal Products for Patients with Uterine Fibroid in Taiwan: A Nationwide Population-Based Study,JOURNAL OF ETHNOPHARMACOLOGY,2015 Aug,171():223-230
SCI論文 顏宏融(Hung-Rong Yen)、(Ching-Ju Liu)、葉家舟*,Naringenin suppresses TPA-induced tumor invasion by suppressing multiple signal transduction pathways in human hepatocellular carcinoma cells,CHEMICO-BIOLOGICAL INTERACTIONS,2015 Jun,235():1-9
SCI論文 顏宏融(Hung-Rong Yen)、(Kai-Li Liang)、(Tzu-Ping Huang)、范芝瑜(Ji-Yu Fan)、張東廸(Tung-Ti Chang)、孫茂峰(SUN, MAO-FENG)*,Characteristics of traditional Chinese medicine use for children with allergic rhinitis: A nationwide population-based study,INTERNATIONAL JOURNAL OF PEDIATRIC OTORHINOLARYNGOLOGY,2015 Apr,79(4):591-597
SCI論文 (Ching-Mao Chang)、朱學亭(Hsueh-Ting Chu)、(Yau-Huei Wei)、(Fang-Pey Chen)、(Shengwen Wang)、吳柏樟(Po-Chang Wu)、顏宏融(Hung-Rong Yen)、(Tzeng-Ji Chen)*、張恒鴻(CHANG,HEN-HONG)*,The Core Pattern Analysis on Chinese Herbal Medicine for Sjögren's syndrome: A Nationwide Population-Based Study,Scientific Reports,2015 Apr,5(9541):
SCI論文 顏宏融(Hung-Rong Yen)、孫茂峰(SUN, MAO-FENG)、林橙莉、宋鴻樟(Fung-Chang Sung)、(Chen-Chi Wang)、(Kai-Li Liang)*,Adjunctive traditional Chinese medicine therapy for patients with chronic rhinosinusitis: a population-based study,International Forum of Allergy & Rhinology,2015 Mar,5(3):240-246
Other論文 張恒鴻*、巫漢揆、顏宏融(Hung-Rong Yen),中醫師畢業後教育,醫療品質,2014 Sep,8(5):4-6
Other論文 余兆蕙、顏宏融(Hung-Rong Yen)*,兒童肥胖的中醫藥治療概述,中國醫藥研究叢刊,2014 Aug,(30):18-26
SCI論文 (Tzu-Ping Huang)、(Pi-Hua Liu)、(Angela Shin-Yu Lien)、(Shu-Ling Yang)、張恒鴻(CHANG,HEN-HONG)、顏宏融(Hung-Rong Yen)*,A Nationwide Population-based Study of Traditional Chinese Medicine Usage in Children in Taiwan,COMPLEMENTARY THERAPIES IN MEDICINE,2014 Jun,22(3):500-510
SCI論文 (Chao-Hui Yu)、(Pi-Hua Liu)、(Yang-Hau Van)、(Angela Shin-Yu Lien)、(Tzu-Ping Huang)、顏宏融(Hung-Rong Yen)*,Traditional Chinese medicine for idiopathic precocious puberty: A hospital-based retrospective observational study,COMPLEMENTARY THERAPIES IN MEDICINE,2014 Apr,22(2):258-265
Other論文 游景卉、顏宏融(Hung-Rong Yen)*、劉碧華,中醫治療子宮內膜異位症之長庚經驗,北市中醫會刊,2014 Mar,20(1):60-66
SCI論文 (Jing-Fan Lin)、(Pi-Hua Liu)、(Tzu-Ping Huang)、(Angela Shin-Yu Lien)、(Liang-Shiou Ou)、(Chin-Hui Yu)、(Shu-Ling Yang)、張恒鴻(CHANG,HEN-HONG)、顏宏融(Hung-Rong Yen)*,Characteristics and prescription patterns of traditional Chinese medicine in atopic dermatitis patients: Ten-year experiences at a medical center in Taiwan,COMPLEMENTARY THERAPIES IN MEDICINE,2014 Feb,22(1):141-147
SCI論文 黃子玶(Tzu-Ping Huang)、劉碧華(Pi-Hua Liu)、連心瑜(Angela Shin-Yu Lien)、楊淑齡(Shu-Ling Yang)、張恒鴻(CHANG,HEN-HONG)、顏宏融(Hung-Rong Yen)*,Characteristics of traditional Chinese medicine use in children with asthma: a nationwide population-based study.,ALLERGY,2013 Dec,68(12):1610-1613
SCI論文 (Satoshi Wada)、(Timothy J. Harris)、(Erik Tryggestad)、(Kiyoshi Yoshimura)、(Jing Zeng)、顏宏融(Hung-Rong Yen)、(Derese Getnet)、(Joseph F. Grosso)、(Tullia C. Bruno)、(Angelo M. De Marzo)、(George J. Netto)、(Drew M. Pardoll)、(Theodore L. DeWeese)、(John Wong)、(Charles G. Drake)*,Combined treatment effects of radiation and immunotherapy: studies in an autochthonous prostate cancer model.,INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS,2013 Nov,87(4):769-776
SCI論文 黃子玶(Tzu-Ping Huang)、張宇涵(Yu-Han Chang)、陳世翔(Shih-Hsiang Chen)、楊淑齡(Shu-Ling Yang)、顏宏融(Hung-Rong Yen)*,Alternative therapy for persistent childhood immune thrombocytopenic purpura unresponsive to intravenous immunoglobulin.,COMPLEMENTARY THERAPIES IN MEDICINE,2013 Oct,21(5):525-528
SCI論文 (Satoshi Wada)、(Christopher M Jackson)、(Kiyoshi Yoshimura)、顏宏融(Hung-Rong Yen)、(Derese Getnet)、(Timothy J Harris)、(Monica V Goldberg)、(Tullia C Bruno)、(Joseph F Grosso)、(Nicholas Durham)、(George J Netto)、(Drew M Pardoll)、(Charles G Drake)*,Sequencing CTLA-4 blockade with cell-based immunotherapy for prostate cancer.,Journal of Translational Medicine,2013 Apr,11():89
SCI論文 (Chung-Fan Hsieh)、顏宏融(Hung-Rong Yen)、(Chih-Hao Liu)、(Shiming Lin)、洪錦堂(Jim-Tong Horng)*,Ching-fang-pai-tu-san inhibits the release of influenza virus.,JOURNAL OF ETHNOPHARMACOLOGY,2012 Dec,144(3):533-544
SCI論文 (Chung-Fan Hsieh)、(Cheng-wei Lo)、(Chih-Hao Liu)、(Shiming Lin)、顏宏融(Hung-Rong Yen)、林奏延(Tzou-Yien Lin)、洪錦堂(Jim-Tong Horng)*,Mechanism by which ma-xing-shi-gan-tang inhibits the entry of influenza virus.,JOURNAL OF ETHNOPHARMACOLOGY,2012 Aug,143(1):57-67
Other論文 張恒鴻(Hen-Hong Chang)*、顏宏融(Hung-Rong Yen)、楊賢鴻(Sien-Hung Yang),教學創新,突破傳統—中醫醫學生OSCE考試,醫療品質,2012 May,6(3):80-82
SCI論文 (Tullia C. Bruno)、(Cristin Rothwell)、(Joseph F. Grosso)、(Derese Getnet)、顏宏融(Hung-Rong Yen)、(Nicholas M. Durham)、(George Netto)、(Drew M. Pardoll)、(Charles G. Drake)*,Anti-tumor effects of endogenous prostate cancer-specific CD8 T cells in a murine TCR transgenic model.,PROSTATE,2012 Apr,72(5):514-522
SCI論文 (Eric V. Dang)、(Joseph Barbi)、(Huang-Yu Yang)、(Dilini Jinasena)、(Hong Yu)、(Ying Zheng)、(Zachary Bordman)、(Juan F)、(Young Kim)、顏宏融(Hung-Rong Yen)、(Weibo Luo)、(Karen Zeller)、(Larissa Shimoda)、(Suzanne L. Topalian)、(Gregg L. Semenza)、(Chi V. Dang)、(Drew M. Pardoll)*、(Fan Pan)*,Control of T(H)17/T(reg) balance by hypoxia-inducible factor 1,CELL,2011 Sep,146(5):772-784
SCI論文 (Ming-Sian Wu)、顏宏融(Hung-Rong Yen)、(Chia-Wen Chang)、(Tsui-Yi Peng)、(Chung-Fan Hsieh)、(Chi-Jene Chen)、林奏延(Tzou-Yien Lin)、洪錦堂(Jim-Tong Horng)*,Mechanism of action of the suppression of influenza virus replication by Ko-Ken Tang through inhibition of the phosphatidylinositol 3-kinase/Akt signaling pathway and viral RNP nuclear export.,JOURNAL OF ETHNOPHARMACOLOGY,2011 Apr,134(3):614-623
SCI論文 (Derese Getnet)、(Joseph F. Grosso)、(Monica V. Goldberg)、(Timothy J. Harris)、顏宏融(Hung-Rong Yen)、(Tullia C. Bruno)、(Nicholas M. Durham)、(Edward L. Hipkiss)、(Kristin J. Pyle)、(Satoshi Wada)、(Fan Pan)、(Drew M. Pardoll)、(Charles G. Drake)*,A role for the transcription factor Helios in human CD4(+)CD25(+) regulatory T cells.,MOLECULAR IMMUNOLOGY,2010 Apr,47(7-8):1595-1600
SCI論文 (Vedran Radojcic)、(Maria A. Pletneva)、顏宏融(Hung-Rong Yen)、(Sanja Ivcevic)、(Angela Panoskaltsis-Mortari)、(Anita C. Gilliam)、(Charles G. Drake)、(Bruce R. Blazar)、(Leo Luznik)*,STAT3 signaling in CD4+ T cells is critical for the pathogenesis of chronic sclerodermatous graft-versus-host disease in a murine model.,JOURNAL OF IMMUNOLOGY,2010 Jan,184(2):764-774
SCI論文 顏宏融(Hung-Rong Yen)、(Timothy J. Harris)、(Satoshi Wada)、(Joseph F. Grosso)、(Derese Getnet)、(Monica V. Goldberg)、梁凱莉(Kai-Li Liang)、(Tullia C. Bruno)、(Kristin J. Pyle)、(Siaw-Li Chan)、(Robert A. Anders)、(Cornelia L. Trimble)、(Adam J. Adler)、林奏延(Tzou-Yien Lin)、(Drew M. Pardoll)、黃景泰(Ching-Tai Huang)、(Charles G. Drake)*,Tc17 CD8 T cells: functional plasticity and subset diversity.,JOURNAL OF IMMUNOLOGY,2009 Dec,183(11):7161-7168
Other論文 張雅婷(Ya-Ting Chang)、沈建忠(Jiann-Jong Shen)、翁雯柔(Wen-Rou Wong)*、顏宏融(Hung-Rong Yen),Alternative therapy for autosensitization dermatitis.,Chang Gung Medical Journal,2009 Nov,32(6):668-673
SCI論文 (Shaoguang Wu)、(Ki-Jong Rhee)、(Emilia Albesiano)、(Shervin Rabizadeh)、(Xinqun Wu)、顏宏融(Hung-Rong Yen)、(David L Huso)、(Frederick L Brancati)、(Elizabeth Wick)、(Florencia McAllister)、(Franck Housseau)*、(Drew M Pardoll)、(Cynthia L Sears)*,A human colonic commensal promotes colon tumorigenesis via activation of T helper type 17 T cell responses.,NATURE MEDICINE,2009 Sep,15(9):1016-1022
SCI論文 (Joseph F. Grosso)、(Monica V. Goldberg)、(Derese Getnet)、(Tullia C. Bruno)、顏宏融(Hung-Rong Yen)、(Kristin J. Pyle)、(Edward Hipkiss)、(Dario A. A. Vignali)、(Drew M. Pardoll)、(Charles G. Drake)*,Functionally distinct LAG-3 and PD-1 subsets on activated and chronically stimulated CD8 T cells,JOURNAL OF IMMUNOLOGY,2009 Jun,182(11):6659-6669
SCI論文 (Satoshi Wada)、(Kiyoshi Yoshimura)、(Edward L. Hipkiss)、(Timothy J. Harris)、顏宏融(Hung-Rong Yen)、(Monica V. Goldberg)、(Joseph F. Grosso)、(Derese Getnet)、(Angelo M. Demarzo)、(George J. Netto)、(Robert Anders)、(Drew M. Pardoll)、(Charles G. Drake)*,Cyclophosphamide Augments Antitumor Immunity: Studies in an Autochthonous Prostate Cancer Model,CANCER RESEARCH,2009 May,69(10):4309-4318
SCI論文 (Derese Getnet)、(Charles H. Maris)、(Edward L. Hipkiss)、(Joseph F. Grosso)、(Timothy J. Harris)、顏宏融(Hung-Rong Yen)、(Tullia C. Bruno)、(Satoshi Wada)、(Adam Adler)、(Robert W. Georgantas)、(Chunfa Jie)、(Monica V. Goldberg)、(Drew M. Pardoll)、(Charles G. Drake)*,Tumor recognition and self-recognition induce distinct transcriptional profiles in antigen-specific CD4 T cells.,JOURNAL OF IMMUNOLOGY,2009 Apr,182(8):4675-4685
SCI論文 (Timothy J. Harris)、(Edward L. Hipkiss)、(Scott Borzillary)、(Satoshi Wada)、(Joseph F. Grosso)、顏宏融(Hung-Rong Yen)、(Derese Getnet)、(Tullia C. Bruno)、(Monica V. Goldberg)、(Drew M. Pardoll)、(Theodore L. DeWeese)、(Charles G. Drake)*,Radiotherapy augments the immune response to prostate cancer in a time-dependent manner.,PROSTATE,2008 Sep,68(12):1319-1329
SCI論文 (Timothy J. Harris)、(Joseph F. Grosso)、顏宏融(Hung-Rong Yen)、(Hong Xin)、(Marcin Kortylewski)、(Emilia Albesiano)、(Edward L. Hipkiss)、(Derese Getnet)、(Monica V. Goldberg)、(Charles H. Maris)、(Franck Housseau)、(Hua Yu)、(Drew M. Pardoll)、(Charles G. Drake)*,Cutting Edge: An in vivo requirement for STAT3 signaling in TH17 development and TH17-dependent autoimmunity.,JOURNAL OF IMMUNOLOGY,2007 Oct,179(7):4313-4317
SCI論文 林胤谷(Yin-Ku Lin)、顏宏融(Hung-Rong Yen)、翁雯柔(Wen-Rou Wong)、楊賢鴻(Sien-Hung Yang)、蘇中慧(Jong-Hwei Su Pang)*,Successful treatment of pediatric psoriasis with indigo naturalis composite ointment.,PEDIATRIC DERMATOLOGY,2006 Sep,23(5):507-510
Other論文 張雅淳(Ya-Chung Chang)、薛宏昇(Horng Sheng Shiue)、張恒鴻(Hen-Hong Chang)*、張晉賢(Chin-Hsien Chang)、楊岳隆(Yueh-Lung Yang)、顏宏融(Hung-Rong Yen),The therapeutic effect of applying herbal paste onto acupoints for allergic rhinitis during dog days - a preliminary study.,Journal of Chinese Medicine,2006 Mar,17(1-2):15-24
SCI論文 顏宏融(Hung-Rong Yen)、林本一(Pen-Yi Lin)*、莊文郁(Wen-Yu Chuang)、章敏玲(Min-Lin Chang)、邱政珣(Cheng-Hsun Chiu),Skin manifestations of Kikuchi-Fujimoto disease: case report and literature review.,EUROPEAN JOURNAL OF PEDIATRICS,2004 Apr,164(4-5):210-213
SCI論文 顏宏融(Hung-Rong Yen)、林瑞瑩(Reyin Lien)*、傅仁暉(Ren-Huei Fu)、張鑾英(Luan-Yin Chang),Hepatic failure in a newborn with maternal peripartum exposure to echovirus 6 and enterovirus 71.,EUROPEAN JOURNAL OF PEDIATRICS,2003 Sep,162(9):648-649
Other論文 趙琇玲(Shiouh-Lirng Chao)、黃莉文(Lee-Wen Huang)*、顏宏融(Hung-Rong Yen),Pregnancy in premature ovarian failure after therapy using Chinese herbal medicine.,Chang Gung Medical Journal,2003 Jun,26(6):449-452
Other論文 顏宏融(Hung-Rong Yen)、朱世明(Shin-Ming Chu)*,Paroxysmal supraventricular tachycardia in neonatal tuberous sclerosis complex and cardiac rhabdomyoma: report of one case.,Acta Paediatrica Taiwanica,2003 Mar,44(2):112-115
 
研討會論文/Conference Papers
(發表主題或論文名稱,研討會名稱,演講地點,研討會期間,受邀演講題目)
1﹒ 針灸減少纖維肌痛症患者罹患腦中風風險 : 台灣全國人口之配對世代研究,2020第90屆國醫節第12屆台北國際中醫藥學術論壇,台北市徐州路2號/台大醫院國際會議中心,2020.7.4 ~ 2020.7.5,
2﹒ 探討生長遲緩兒童使用cyproheptadine治療與身材變化的關聯性:單一醫學中心回溯性觀察型研究,台灣兒科醫學會第240屆學術演講會,臺北國際會議中心,2019.11.9 ~ 2019.11.10,
3﹒ ,第34屆天然藥物研討會,Taoyuan/ Chang Gung University of Science and Technology,2019.10.17 ~ 2019.10.19,Traditional Chinese Medicine for Cancer Patients in Taiwan
4﹒ ,第三期小兒推拿研習班兒童生長常見疾病,高雄長庚紀念醫院,2019.10.19 ~ 2019.10.19,
5﹒ Leuprolide treatment for earlier puberty girls with body composition change: A retrospective cohort study,108學年度 菁英博士生競賽暨研究生壁報比賽,中國醫藥大學立夫教學大樓 6樓,2019.10.15 ~ 2019.10.15,
6﹒ ,International Symposium on Traditional Medicines Non-communicable diseases,Bangkok, Thailand,2019.9.11 ~ 2019.9.12,Traditional Chinese Medicine in the Management of Non-Communicable Diseases
7﹒ Adjunctive Chinese Herbal Medicine Improves Nasopharyngeal Carcinoma Patient Survival and Induces Tumor Apoptosis: Clinical Evidence and Experimental Validation,The 3rd CMU-NUS JOINT SYMPOSIUM,台中長榮,2019.8.30 ~ 2019.8.30,
8﹒ ,The 3rd CMU-NUS JOINT SYMPOSIUM,Taichung / Evergreen Laurel Hotel,2019.8.30 ~ 2019.8.30,Adjunctive Chinese Herbal Medicine Improves Nasopharyngeal Carcinoma Patient Survival and Induces Tumor Apoptosis: Clinical Evidence and Experimental Validation
9﹒ Chinese herbal compound synergized with anti-IL-17RA as a novel cancer immunotherapeutic strategy to fight against pancreatic cancer,The 3rd CMU-NUS JOINT SYMPOSIUM,Taichung / Evergreen Laurel Hotel,2019.8.30 ~ 2019.8.30,
10﹒ The Effects of Complementary Chinese Herbal Medicine on pancreatic cancer,The 3rd CMU-NUS JOINT SYMPOSIUM,Taichung / Evergreen Laurel Hotel,2019.8.30 ~ 2019.8.30,
11﹒ Effects of the Integrated TCM Care Program on Quality of Sleep and Immunology on Pediatric Allergic Rhinitis with Sleep Disordered Breathing: A Case Series Study.,第五屆中醫中藥發展論壇暨第十一屆全球傳統醫學大學聯盟年會,香港浸會大學,2019.6.29 ~ 2019.6.30,
12﹒ ,2019 中醫藥學術研討會【從計畫撰寫、中藥轉譯研究到論文發表】 學術研討會,Taichung / 中國醫藥大學,2019.6.9 ~ 2019.6.9,Introduction of “Complementary Therapies in Medicine” and get your paper published
13﹒ Integrated TCM Care Program Combined with Intranasal Corticosteroids to Treat Pediatric Obstructive Sleep Apnea: A Case Series Study,14th International Congress on Complementary Medicine Research,Brisbane Convention & Exhibition Center in Brisbane,Australia,2019.5.7 ~ 2019.5.10,
14﹒ ,108年衛生福利部桃園醫院中醫藥「兒童暨青少年中醫特色醫療」學術研討會,衛生福利部桃園醫院,2019.5.26 ~ 2019.5.26,中醫兒科轉譯研究
15﹒ Inhibition of dendritic cells and Th17 cells by a flavonoid compound attenuates clinical severities in a murine collagen-induced arthritis model,(IMMUNOLOGY 2019TM) THE ANNUAL MEETING OF THE AMERICAN ASSOCIATION OF IMMUNOLOGISTS,SAN DIEGO,2019.5.9 ~ 2019.5.13,
16﹒ The effect of Chinese herbal medicine compound, CS029, in suppression of dendritic cells and its therapeutic application in experimental autoimmune encephalomyelitis.,(IMMUNOLOGY 2019TM) THE ANNUAL MEETING OF THE AMERICAN ASSOCIATION OF IMMUNOLOGISTS,San Diego, USA,2019.5.9 ~ 2019.5.13,
17﹒ ,2019 CMU-NUS Joint Symposium in Herbal Medicine and New Drug Development,立夫教學大樓第一會議室,2019.4.24 ~ 2019.4.24,An Overview of the Small-Molecule Drug Discovery Program
18﹒ ,2019第89屆國醫節第11屆台北國際中醫藥學術論壇,臺大醫院國際會議中心,2019.3.9 ~ 2019.3.10,兒童異位性皮膚炎中藥臨床治療經驗分享
19﹒ Psoralea corylifolia L. Ameliorates Collagen-induced Arthritis through the Up-regulation of Myeloid-derived Suppressor Cells,The 2nd CMU-MU Joint Symposium,Taichung / Evergreen Laurel Hotel,2019.1.3 ~ 2019.1.4,
20﹒ ,The 2nd CMU-MU Joint Symposium,Taichung / Evergreen Laurel Hotel,2019.1.3 ~ 2019.1.4,Traditional Chinese Medicine in Taiwan
21﹒ ,中華針灸醫學會第八屆第一次會員大會暨師古鑑今開創新猷學術研討會,台中/中國醫藥大學,2019.1.20 ~ 2019.1.20,針灸治療纖維肌痛症:整合大數據-基礎實驗-臨床試驗的轉譯醫學研究
22﹒ ,1st PAPRSB INSETITUTE OF HEALTH SCIENCES UNIVERSITI BRUNEI DARUSSALAM AND CHINA MEDICAL UNIVERSITY JOINT SCIENTIFIC SYMPOSIUM 2019,汶萊,2019.1.16 ~ 2019.1.16,Adoptive Transfer of CD8 Tc17 Cells Elicits Anti-Tumor Immunity Through Functional Plasticity
23﹒ Blockade of Interleukin-17A Synergized with Inhibition of Mitochondrial Uncoupling Protein 2 as a Novel Strategy to Promote Anti-tumor Immunity against Pancreatic Cancer,The 2nd CMU-MU Joint Symposium,Taichung / Evergreen Laurel Hotel,2019.1.3 ~ 2019.1.4,
24﹒ Adjunctive Chinese Herbal Medicine Improves Nasopharyngeal Carcinoma Patient Survival and Induces Tumor Apoptosis: Clinical Evidence and Experimental Validation,The 2nd CMU-MU Joint Symposium,Taichung / Evergreen Laurel Hotel,2019.1.3 ~ 2019.1.4,
25﹒ 3H-1,2-dithiole-3-thione as a Novel Therapeutic Agent for the Treatment of Imiquimod Induced Psoriasis-liked Skin Inflammation,The 2nd CMU-MU Joint Symposium,Taichung / Evergreen Laurel Hotel,2019.1.3 ~ 2019.1.4,
26﹒ Cognitive Deficits in the Early Stage of Multiple Sclerosis,The 2nd CMU-MU Joint Symposium,Taichung / Evergreen Laurel Hotel,2019.1.3 ~ 2019.1.4,
27﹒ Trends in the Utilization of Acupuncture among Children in Taiwan from 2002 to 2011: A Nationwide Population-Based Study,2018年中西整合系列學術研討會,中國醫藥大學教學立夫大樓,2018.12.9 ~ 2018.12.9,
28﹒ Acupuncture use of adults in Taiwan from 2002 to 2011: a nationwide population-based study,第19屆國際東洋醫學學術大會,台大國際會議中心,2018.11.24 ~ 2018.11.26,
29﹒ Combined with Chinese and Western Medicine for Treatment of Preterm Premature Rapture of Membrane-A case report,第19屆國際東洋醫學學術大會,National Taiwan University Hospital International Convention Center,2018.11.24 ~ 2018.11.26,
30﹒ 探討早發育女童使用促性腺激素釋放素促進劑治療與身材變化的關聯性:一回溯性世代研究,台灣兒科醫學會第二三六屆學術演講會,國立成功大學醫學院成杏校區,2018.11.17 ~ 2018.11.18,
31﹒ Review of Traditional Literature and Clinical Trials of Acupuncture in Acute Exacerbation of Rheumatoid Arthritis,第19屆國際東洋醫學學術大會,National Taiwan University Hospital International Convention Center, Taipei, Taiwan, 3rd Floor,2018.11.24 ~ 2018.11.26,
32﹒ Cognitive deficits in the early stage of multiple sclerosis,2018 2nd CMU-HYU Joint Symposium,Taichung / Evergreen Laurel Hotel,2018.11.23 ~ 2018.11.23,
33﹒ Blockade of interleukin-17A synergized with inhibition of mitochondrial uncoupling protein 2 as a novel strategy to promote anti-tumor immunity against pancreatic cancer,2018 2nd CMU-HYU Joint Symposium,Taichung / Evergreen Laurel Hotel,2018.11.23 ~ 2018.11.23,
34﹒ Adjunctive Chinese Herbal Medicine Improves Nasopharyngeal Carcinoma Patient Survival and Induces Tumor Apoptosis: Clinical Evidence and Experimental Validation,2018 2nd CMU-HYU Joint Symposium,Taichung / Evergreen Laurel Hotel,2018.11.23 ~ 2018.11.23,
35﹒ ,2018 2nd CMU-HYU Joint Symposium,Taichung / Evergreen Laurel Hotel,2018.11.23 ~ 2018.11.23,Adoptive transfer of CD8 Tc17 Cells elicits anti-tumor immunity through functional plasticity
36﹒ Trends in Use of Acupuncture in Taiwan,WSCDA Worldwide Scientific and Cultural Dialogue on Acupuncture,UNESCO總部(法國巴黎),2018.11.16 ~ 2018.11.17,
37﹒ ,WSCDA Worldwide Scientific and Cultural Dialogue on Acupuncture,UNESCO總部(法國巴黎),2018.11.16 ~ 2018.11.17,Acupuncture for the Treatment of Fibromyalgia: a Big data-Bench-Bedside study
38﹒ 3H-1,2-dithiole-3-thione as a novel therapeutic agent for the treatment of imiquimod induced psoriasis-liked skin inflammation,2018 2nd CMU-HYU Joint Symposium,Taichung / Evergreen Laurel Hotel,2018.11.23 ~ 2018.11.23,
39﹒ Psoralea corylifolia L. Ameliorates Collagen-induced Arthritis through the Up-regulation of Myeloid-derived Suppressor Cells,2018 2nd CMU-HYU Joint Symposium,Taichung / Evergreen Laurel Hotel,2018.11.23 ~ 2018.11.23,
40﹒ The Efficacy and Mechanism of Calycosin in a Murine Cold stress-induced Fibromyalgia model.,第19屆國際東洋醫學學術大會,Taipei / 台大國際會議中心,2018.11.24 ~ 2018.11.26,
41﹒ Adjunctive Chinese Herbal Medicine Improves Nasopharyngeal Carcinoma Patient Survival and Induces Tumor Apoptosis: Clinical Evidence and Experimental Validation,第19屆國際東洋醫學學術大會,Taipei / 台大國際會議中心,2018.11.24 ~ 2018.11.26,
42﹒ Psoralea corylifolia L. Ameliorates Collagen-induced Arthritis through the Up-regulation of Myeloid-derived Suppressor Cells,第19屆國際東洋醫學學術大會,Taipei / 台大國際會議中心,2018.11.24 ~ 2018.11.26,
43﹒ Luteolin as a novel therapeutic agent for the treatment of allergic rhinitis,第19屆國際東洋醫學學術大會,Taipei / 台大國際會議中心,2018.11.24 ~ 2018.11.26,
44﹒ Literature Review of Traditional Chinese Medicine for the Management of Enterovirus Infection with Severe Complications,第19屆國際東洋醫學學術大會,National Taiwan university hospital international convention center, Taipei, Taiwan,2018.11.24 ~ 2018.11.26,
45﹒ ,WCTM 2018 World Congress on Traditional Medicine,Bangkok Thailand,2018.10.22 ~ 2018.10.23,Characteristics of Traditional Chinese Medicine Usage in Patients with Stroke in Taiwan: A Nationwide Population-based Study
46﹒ ,107年度衛福部建構中西合作照護模式計畫-兒童過敏性鼻炎合併睡眠呼吸障礙中西醫合作照護成果發表會,中國醫藥大學立夫教學大樓,2018.10.28 ~ 2018.10.28,從西醫觀點談兒童過敏性鼻炎與相關併發症
47﹒ IL-17 secreted by gd T cells could induce psoriasis and NFkB signal transduction in keratinocyte,生物醫學國際研討會暨第15屆前瞻生物醫學科學新知研討會,中國醫藥大學,2018.6.29 ~ 2018.6.30,
48﹒ A novel adjuvant strategy for peptide-based vaccine through enhancing effector and memory T cells to against HPV-related tumor,2018生物醫學國際研討會暨第15屆前瞻生物醫學科學新知研討會,Taichung / 中國醫藥大學,2018.6.29 ~ 2018.6.30,
49﹒ Cognitive Deficits in The Early Stage of Experimental Autoimmune Encephalitis.,生物醫學國際研討會暨第15屆前瞻生物醫學科學新知研討會,Taichung / 中國醫藥大學,2018.6.29 ~ 2018.6.30,
50﹒ Blockade of interleukin-17A synergized with inhibition of mitochondrial uncoupling protein 2 as a novel strategy to promote anti-tumor immunity against pancreatic cancer,生物醫學國際研討會暨第15屆前瞻生物醫學科學新知研討會,Taichung / 中國醫藥大學,2018.6.29 ~ 2018.6.30,
51﹒ The efficacy and mechanism of Chinese herbal medicine on the induction of specific anti-tumor response,Immunology 2018atVienna,Vienna, Austria,2018.6.5 ~ 2018.6.7,
52﹒ Trends in Use of Acupuncture Among Adults in Taiwan from 2002 to 2011: A Nationwide Population-based Study,第十屆全球傳統醫學大學聯盟論壇 亞太整合醫學研討會,中國醫藥大學,2018.5.25 ~ 2018.5.26,
53﹒ ,2018 2nd CMU-NUS Joint Symposium,Taichung / Freshfields Hotel,2018.5.21 ~ 2018.5.22,Adoptive transfer of CD8 Tc17 cells elicits anti-tumor immunity through functional plasticity
54﹒ A novel adjuvant strategy for peptide-based vaccine through enhancing effector and memory T cells to against HPV-related tumor.,2018 2nd CMU-NUS Joint Symposium,Taichung / Freshfields Hotel,2018.5.21 ~ 2018.5.22,
55﹒ Integrative Traditional Chinese Medicine Therapy Reduces The Risk Of Type 2 Diabetes In Patients With Polycystic Ovary Syndrome,第十屆全球傳統醫學大學聯盟論壇 亞太整合醫學研討會,台中/中國醫藥大學,2018.5.25 ~ 2018.5.26,
56﹒ Pattern of Chinese Herbal Medicines Utilization in Patients with Postpartum Mastitis in Taiwan: A Nationwide Population-based Study,第十屆全球傳統醫學大學聯盟論壇 亞太整合醫學研討會,台中/中國醫藥大學,2018.5.25 ~ 2018.5.26,
57﹒ Inhibition of Immune Checkpoint PD-1 Expression by Chinese Herbal Medicine for Cancer Immunotherapy,第十屆全球傳統醫學大學聯盟論壇 亞太整合醫學研討會,台中/中國醫藥大學,2018.5.25 ~ 2018.5.26,
58﹒ Integrative Chinese Herbal Medicine Therapy Improves Survival of Patients with Pancreatic Cancer in Taiwan,第十屆全球傳統醫學大學聯盟論壇 亞太整合醫學研討會,台中/中國醫藥大學,2018.5.25 ~ 2018.5.26,
59﹒ Characteristics of traditional Chinese medicine usage in children with precocious puberty,第十屆全球傳統醫學大學聯盟論壇 亞太整合醫學研討會,台中/中國醫藥大學,2018.5.25 ~ 2018.5.26,
60﹒ Integrative Traditional Chinese Medicine Therapy Reduces Medical Expenditure for Hospitalization in Patients with Fractures in Taiwan: A Nationwide Population-based Study,第十屆全球傳統醫學大學聯盟論壇 亞太整合醫學研討會,台中/中國醫藥大學,2018.5.25 ~ 2018.5.26,
61﹒ Characteristics of traditional Chinese medicine usage in children with precocious puberty,第十屆全球傳統醫學大學聯盟論壇 亞太整合醫學研討會,中國醫藥大學,2018.5.25 ~ 2018.5.26,
62﹒ 臺灣筋骨草水萃取物抑制人類大腸癌細胞株生長之研究,32屆國際天然藥物研討會 (THE 32nd INTERNATIONAL SYMPOSIUM ON NATURAL PRODUCTS),中國醫藥大學,2017.10.13 ~ 2017.10.14,
63﹒ Study on the antiproliferative activity of Ajuga taiwanensis Nakai ex Murata aqueous extract in human colon cancer cell,32屆國際天然藥物研討會 (THE 32nd INTERNATIONAL SYMPOSIUM ON NATURAL PRODUCTS),中國醫藥大學B1國際會議廳,2017.10.13 ~ 2017.10.14,
64﹒ Acupuncture Decreased the Risk of Coronary Heart Disease in Fibromyalgia Patients in Taiwan: A Nationwide Propensity Score Matched Cohort Study,THE 16th MEETING OF CONSORTIUM FOR GLOBALIZATION OF CHINESE MEDICINE 2017,中國廣州白雲國際會議中心,2017.8.18 ~ 2017.8.20,
65﹒ Functional plasticity of human Tc17 cells is dependent on cytokine milieu,IMMUNOLOGY 2017,Water E. Washington Convention Center, Washington D.C., U.S.A,2017.5.12 ~ 2017.5.16,
66﹒ Combination of Peptide-based Vaccine and Chinese Herbal Medicine as a Strategy to Enhance Immune responses in Virus-associated Cancer,Immunology 2017,Washington, DC,2017.5.12 ~ 2017.5.16,
67﹒ Association of Traditional Chinese Medicine Therapy and the Risk of Vascular Complications in Patients With Type II Diabetes Mellitus: A Nationwide, Retrospective, Taiwanese-Registry, Cohort Study,International Conference of World Federation of Acupuncture–Moxibustion Societies Tokyo/Tsukuba 2016,Tokyo/Tsukuba, Japan,2016.11.5 ~ 2016.11.6,
68﹒ Acupuncture for Treatment of Chemotherapy-Induced peripheral Neuropathy: A Systematic Review of Randomized Controlled Trials,International Conference of World Federation of Acupuncture–Moxibustion Societies Tokyo/Tsukuba 2016,Tokyo/Tsukuba, Japan,2016.11.5 ~ 2016.11.6,
69﹒ Effects of Moderate to Severe Periodic Limb Movement in Sleep (PLMS) on Sleep parameters,23rd Congress of the European Sleep Research Society,Bologna, Italy,2016.9.13 ~ 2016.9.16,
70﹒ The Core Pattern of Traditional Chinese Medicine Formula for Patients with Systemic Sclerosis in Taiwan.,The 15th Meeting of the Consortium for Globalization of Chinese Medicine,Taipei,2016.8.22 ~ 2016.8.26,
71﹒ TCM tongue diagnosis in primary Sjogren’s syndrome with or without positive anti-SSA/SSB antibodies.,The 15th Meeting of the Consortium for Globalization of Chinese Medicine,Taipei,2016.8.22 ~ 2016.8.26,
72﹒ Characteristics of Traditional Chinese Medicine Usage in children with Sexual precocity: A nationwide population-based study,18th ICOM,沖繩,2016.4.15 ~ 2016.4.17,
73﹒ Prescription patterns of traditional Chinese medicine for Crohn’s disease in Taiwan,第九屆中國醫藥大學暨亞洲大學生物科技研討會-生技產業發展與趨勢,中國醫藥大學立夫大樓B1國際會議廳,2016.3.14 ~ 2016.3.14,
74﹒ The utilization of traditional Chinese medicine for patients with ulcerative colitis in Taiwan: A nationwide population-based study,第九屆中國醫藥大學暨亞洲大學生物科技研討會-生技產業發展與趨勢,中國醫藥大學立夫大樓B1國際會議廳,2016.3.14 ~ 2016.3.14,
75﹒ 以雷射針灸治療透析患者皮膚搔癢症,腎臟醫學會年會-104年,高雄,2015.11.28 ~ 2015.11.29,
76﹒ Traditional Chinese Medicine Research: Big data, Bench, and Bedside,2015 GUNTM,Kyung Hee University, Seoul, Korea,2015.11.4 ~ 2015.11.5,
77﹒ Characteristics of Traditional Chinese Medicine Use in Patients with Rheumatoid Arthritis in Taiwan: a Nationwide Population-Based Study,The Thirteenth Meeting of Consortium for Globalization of Chinese Medicine,Beijing, China,2015.8.27 ~ 2015.8.29,
78﹒ Traditional Chinese Medicine Usage in Taiwan: A Nationwide Population-based Study.,The 14th Meeting of Consortium for Globalization of Chinese Medicine,Western University, London, Canada,2015.8.18 ~ 2015.8.20,
79﹒ ,46th International TCM Kongress,Rothenburg o.d.T., Germany,2015.5.12 ~ 2015.5.16,Adjunctive TCM Use in Cancer Patients: Experience from Taiwan
80﹒ Characteristics of Traditional Chinese Medicine Use for the Elderly Patients in Taiwan A Nationwide Population-based Study,第18屆東洋醫學會,日本沖繩傳統中心,2015.4.15 ~ 2015.4.17,
81﹒ ,1st International Journey: Chinese Herbs,Sao Paulo, Brazil,2015.3.7 ~ 2015.3.7,Scientific Methodology in Chinese Herbal Medicine: characteristics and challenges
82﹒ Characteristics and Prescription Pattern of Traditional Chinese Medicine Use in Patients with Stroke in Taiwan,The 13th Meeting of Consortium for Globalization of Chinese Medicine,中國北京國際會議中心,2014.8.27 ~ 2014.8.29,
83﹒ Characteristics of Traditional Chinese Medicine Use in Patients with Rheumatoid Arthritis in Taiwan: a Nationwide Population-Based Study,The 13th Meeting of the Consortium for Globalization of Chinese Medicine,Beijing, China,2014.8.27 ~ 2014.8.29,
84﹒ Adjunctive traditional Chinese medicine therapy for Patients with Chronic Rhinosinusitis: A Population-based Study,The 13th Meeting of the Consortium for Globalization of Chinese Medicine,Beijing, China,2014.8.27 ~ 2014.8.29,
85﹒ Characteristics and Prescription Pattern of Traditional Chinese Medicine Use in Patients with Stroke in Taiwan: a Nationwide Population-Based Study,The 13th Meeting of the Consortium for Globalization of Chinese Medicine,Beijing, China,2014.8.27 ~ 2014.8.29,
86﹒ Does the Adjunctive Traditional Chinese Medicine Use Reduce the Need for Surgery in Patients with Osteoarthritis? - A Nationwide Population - Based Study in Taiwan,The 13th Meeting of the Consortium for Globazation of Chinese Medicine,Beijing, China,2014.8.27 ~ 2014.8.29,
87﹒ Adjunctive traditional Chinese medicine therapy for Patients with Chronic Rhinosinusitis: A Population-based Study.,The Thirteenth Meeting of Consortium for Globalization of Chinese Medicine,Beijing, China,2014.8.27 ~ 2014.8.29,
88﹒ Does the Adjunctive Traditional Chinese Medicine Use Reduce the Need for Surgery in Patients with Osteoarthritis? –A Nationwide Population-Based Study in Taiwan.,The Thirteenth Meeting of Consortium for Globalization of Chinese Medicine,Beijing, China,2014.8.27 ~ 2014.8.29,
89﹒ Characteristics and Prescription Pattern of Traditional Chinese Medicine Use in Patients with Stroke in Taiwan: a Nationwide Population-Based Study.,The Thirteenth Meeting of Consortium for Globalization of Chinese Medicine,Beijing, China,2014.8.27 ~ 2014.8.29,
90﹒ IL-23 Maintains Tc17 CD8 T Cell Phenotype but not Commitment to IL-17 Production,The 101th Annual Meeting of The American Association of Immunologists,Pittsburgh, Pennsylvania, U.S.A.,2014.5.2 ~ 2014.5.5,
91﹒ Impact of a Comprehensive Traditional Chinese Medicine Day Care Clinical Service on the Health Quality Improvement and Outcome for Children with Asthma,30th ISQua Conference,Edinburgh, U.K.,2013.10.13 ~ 2013.10.16,
92﹒ Characteristics and Prescription Patterns of Traditional Chinese Medicine in Endometriosis Patients: Ten-year Experiences at a Medical Center in Taiwan,The 12th Meeting of the Consortium for Globalization of Chinese Medicine,Graz, Austria,2013.8.26 ~ 2013.8.29,
93﹒ Traditional Chinese Medicine for Persistent Childhood Immune Thrombocytopenic Purpura Unresponsive to Intravenous Immunoglobulin,The 2013 Annual General Meeting of The Register of Chinese Herbal Medicine,London, U.K.,2013.7.6 ~ 2013.7.7,Traditional Chinese Medicine for Persistent Childhood Immune Thrombocytopenic Purpura Unresponsive to Intravenous Immunoglobulin.
94﹒ Resveratrol and its derivatives modulates TH17 differentiation and attenuates experimental autoimmune encephalomyelitis,The 100th Annual Meeting of The American Association of Immunologists,Honolulu, Hawaii, U.S.A.,2013.5.3 ~ 2013.5.7,
95﹒ Herbal paste on accupoints on dog days for preventing allergic diseases.,The 16th International Congress of Oriental Medicine,Seoul, Korea,2012.9.14 ~ 2012.9.16,
96﹒ Implementation of a clinical competence evaluation program in Traditional Chinese Medicine, TCM-OSCE, in Taiwan,The 16th International Congress of Oriental Medicine,Seoul, Korea,2012.9.14 ~ 2012.9.16,
97﹒ Adoptive transfer of Tc17 CD8 T cells as an approach to elicit a better immune response to vaccination,The 99th Annual Meeting of The American Association of Immunologists,Boston, Massachusetts, U.S.A.,2012.5.4 ~ 2012.5.8,
98﹒ ,Harmonizing the ancient wisdom into a modern concept –sharing practical TCM experiences with experts,London, U.K.,2011.10.10 ~ 2011.10.10,TCM treatment for asthma in children
99﹒ OMM and TCM: Comparisons of manipulative treatment.,American Osteopathic Association 115th Annual Osteopathic Medical Conference & Exposition (OMED),San Francisco, California, U.S.A.,2010.10.24 ~ 2010.10.24,
100﹒ Adoptive transfer of Tc17 CD8 T cells leads to tumor inhibition and anti-tumor response.,The 97th Annual Meeting of The American Association of Immunologists,Baltimore, Maryland, U.S.A.,2010.5.7 ~ 2010.5.11,
101﹒ Enterotoxigenic Bacteroides fragilis colonic infection promotes colon tumorigenesis in Apc+/min mice via activation of Th17 T cell responses.,Digestive Disease Week 2009,Chicago, U.S.A.,2009.5.30 ~ 2009.6.4,
102﹒ PRX303 is an IL-2 proaerolysin fusion protein toxin that selectively targets and kills foxp3 regulatory T cells: potential role as a vaccine adjuvant,Targeted Cancer Therapies,Whistler, British Columbia, Canada,2009.3.27 ~ 2009.4.1,
103﹒ Tc17 CD8 T cells: functional plasticity, subset diversity and anti-tumor activity,The 16th Annual Prostate Cancer Foundation (PCF) Scientific Retreat,New York, U.S.A.,2009.2.23 ~ 2009.2.25,
104﹒ Cyclophosphamide augments anti-tumor immunity: studies in an autochthonous prostate cancer model,Mobilizing Cellular Immunity for Cancer Therapy,Snowbird, Utah, U.S.A.,2009.1.11 ~ 2009.1.16,
105﹒ Simultaneous accumulation of functionally impaired anti-tumor CD8 T cells and reduced tumor growth in a double transgenic system,Mobilizing Cellular Immunity for Cancer Therapy,Snowbird, Utah, U.S.A.,2009.1.11 ~ 2009.1.16,
106﹒ A novel role for Helios in induced regulatory T cells,Mobilizing Cellular Immunity for Cancer Therapy,Snowbird, Utah, U.S.A.,2009.1.11 ~ 2009.1.16,
107﹒ Functional distinct LAG-3 and PD-1 subsets on activated and tolerized CD8 T cells,Mobilizing Cellular Immunity for Cancer Therapy,Snowbird, Utah, U.S.A.,2009.1.11 ~ 2009.1.16,
 
專書/Books
(作者,書名,出版商,出版日期)
1﹒ 賴琬郁(Wan-Yu Lai)、顏宏融(Hung-Rong Yen)、高修安、朱錦善*,兒科心鑑,中國中醫藥出版社,2020.4
2﹒ 廖婉婷、柯雅琳、顏宏融(Hung-Rong Yen),中醫臨床有效案例彙編(一),,2017.3
3﹒ 顏宏融(Hung-Rong Yen)*,6歲前,關閉孩子的過敏基因:中醫兒科名醫的獨門秘訣,如何出版社,2015.9
4﹒ 顏宏融(Hung-Rong Yen)*、謝明儒(Ming-Ju Hsieh)、楊賢鴻(Sien-Hung Yang)、張恒鴻(Hen-Hong Chang),第十一章:其他醫事領域OSCE 執行實務—中醫篇。李石增主編,客觀結構式臨床測驗--從基礎建立到執行與品質監測,台灣愛思唯爾,2012.10
 
研究計畫/Research Grant
(研究類型,研究計畫代號,主持人,補助或委託單位名稱,計畫名稱,研究經費,計畫期間)
1﹒ 個別型,MOST 108-2320-B-039-024-MY3,顏宏融(Hung-Rong Yen),吳恒祥(Wu, Heng-Hsiung),科技部,以阻斷細胞激素-17A協同中草藥化合物作為對抗胰臟癌的新穎癌症免疫治療策略,$1600000,2021.8.1 ~ 2022.7.31
2﹒ 個別型,MOST 107-2320-B-039-021-MY3,宋瑛琪(Ying-Chyi Song),顏宏融(Hung-Rong Yen),科技部,蟲草素在抑制樹突細胞及應用於治療多發性硬化症扮演的角色,$1300000,2020.8.1 ~ 2021.7.31
3﹒ 個別型,MOST 108-2320-B-039-024-MY3,顏宏融(Hung-Rong Yen),吳恒祥(Wu, Heng-Hsiung),科技部,以阻斷細胞激素-17A協同中草藥化合物作為對抗胰臟癌的新穎癌症免疫治療策略,$1600000,2020.8.1 ~ 2021.7.31
4﹒ 個別型,CMU109-ASIA-11,許游章(You-Cheng Hseu),顏宏融(Hung-Rong Yen)、黃佩珍,本校(含附醫),預防乾癬/紫外線誘導皮膚癌/皮膚光老化之分子機制探討,$400000,2020.8.1 ~ 2021.7.31
5﹒ 個別型,DMR-HHC-109-9,魏長菁(Chang-Ching Wei),顏宏融(Hung-Rong Yen)、吳伯元(Po-Yuan Wu)、賴琬郁(Wan-Yu Lai),附醫院內計畫,我們‟異”起來: 異位性皮膚炎兒童全人、整合、結構化整合照護,$300000,2020.5.1 ~ 2021.4.30
6﹒ 個別型,DMR-HHC-109-4,賴琬郁(Wan-Yu Lai),顏宏融(Hung-Rong Yen)、魏長菁(Chang-Ching Wei)、林建亨(Chien-Heng Lin)、王清源(Ching-Yuan Wang)、黃得韻(Ng Teik Ying),附醫院內計畫,建構「兒童過敏性鼻炎合併阻塞型睡眠呼吸中止症」中西醫合作照護模式-從預防到治療之全人照護。,$400000,2020.5.1 ~ 2021.4.30
7﹒ 個別型,109111B3,顏宏融(Hung-Rong Yen),賴榮年(Jung-Nien Lai)、吳美瑤(Mei-Yao Wu),衛福部,常見中醫藥輔助治療臨床效益評估ˍ非小細胞肺癌中醫藥輔助治療處方型態、預後及安全性研究,$750000,2020.4.29 ~ 2020.12.31
8﹒ 個別型,採購案號:M09G1047,顏宏融(Hung-Rong Yen),吳美瑤(Mei-Yao Wu)、蘇奕彰、張詩聖(Shih-Sheng Chang)、郭錦輯(Chin-Chi Kuo)、吳亞倫(WU YA-LUN)、宋瑛琪(Ying-Chyi Song)、蔡輔仁(Fuu-Jen Tsai),衛福部,109年度「建立中醫精準醫學計畫」,$2700000,2020.2.6 ~ 2020.12.15
9﹒ 個別型,MOHW109-CMAP-M-114-000403,顏宏融(Hung-Rong Yen),洪瑞鴻(HUNG JUI-HUNG)、林宏任(Hung-jen Lin)、李育臣(Yu-Chen Lee)、蘇珊玉(Shan-Yu Su)、黃敬軒(Ching-Hsuan Huang)、張惠美(Hui-Mei Chang)、許原山(Yuan-Shan Hsu)、蔡邱轔(Chiu-Lin Tsai)、賴琬郁(Wan-Yu Lai)、林怡君(Yi-Chun Lin)、賴榮年(Jung-Nien Lai),衛福部,109年度「中醫藥衛生教育多元推廣」,$1600000,2020.2.6 ~ 2020.12.31
10﹒ 個別型,採購案號:M09G6088,顏宏融(Hung-Rong Yen),楊成湛、林怡君(Yi-Chun Lin)、賴東淵、張東?(Tung-Ti Chang),衛福部,109年度「中醫專科醫師甄審及試辦輔導計畫」(分項計畫4:中醫兒科),$160000,2020.1.21 ~ 2020.11.30
11﹒ 個別型,M09G1025,李育臣(Yu-Chen Lee),蘇冠賓(Kuan-Pin Su)、賴榮年(Jung-Nien Lai)、顏宏融(Hung-Rong Yen)、陳亮宇(Liang-Yu Chen),衛福部,109年度促進中醫多元發展計畫-分項3-建立中醫日間照護計畫,$1350000,2020.1.1 ~ 2021.12.15
12﹒ 整合型(召集人、總主持人),MOHW109-TDU-B-212-134024,趙坤山(Kun-San Chao),周德陽(Der-Yang Cho)、顏宏融(Hung-Rong Yen),衛福部,第3期癌症研究癌症中心計畫-創新醫療技術與中西整合醫療之癌症研究計畫(第三年),$10200000,2020.1.1 ~ 2020.12.31
13﹒ 個別型,CMU108-MF-65,宋瑛琪(Ying-Chyi Song),顏宏融(Hung-Rong Yen),本校(含附醫),蟲草素在抑制樹突細胞及應用於治療多發性硬化症扮演的角色,$300000,2019.9.9 ~ 2020.7.31
14﹒ 個別型,MOST 107-2320-B-039-021-MY3,宋瑛琪(Ying-Chyi Song),顏宏融(Hung-Rong Yen),科技部,蟲草素在抑制樹突細胞及應用於治療多發性硬化症扮演的角色,$1100000,2019.8.1 ~ 2020.7.31
15﹒ 個別型,MOST 108-2320-B-039-033-,張東廸(Tung-Ti Chang),顏宏融(Hung-Rong Yen),科技部,中藥紫檀芪對氣喘的作用與機轉研究,$1050000,2019.8.1 ~ 2020.7.31
16﹒ 非研究型計畫-教學實踐研究計畫,10871705,顏宏融(Hung-Rong Yen),賴琬郁(Wan-Yu Lai),教育部,教學實踐計畫-建構中醫小兒推拿臨床實務教學模式,$415150,2019.8.1 ~ 2020.7.31
17﹒ 個別型,DMR-109-002,林怡君(Yi-Chun Lin),王仲興(Chung-Hsing Wang)、顏宏融(Hung-Rong Yen),附醫院內計畫,特發性性早熟及早發育女童使用leuprolide(Luprondepot-PED-1 month:Leuprorelin)治療效果:單一醫學中心之回溯性觀察型研究(第二階段),$425000,2019.8.1 ~ 2020.7.31
18﹒ 個別型,MOST 108-2320-B-039-024-MY3,顏宏融(Hung-Rong Yen),吳恒祥(Wu, Heng-Hsiung),科技部,以阻斷細胞激素-17A協同中草藥化合物作為對抗胰臟癌的新穎癌症免疫治療策略,$1700000,2019.8.1 ~ 2020.7.31
19﹒ 個別型,DMR-109-009,黃明正(Ming-Cheng Huang),孫茂峰(Mao-Feng Sun)、顏宏融(Hung-Rong Yen)、廖厚勳(Hou-Hsun Liao),附醫院內計畫,應用穴位電刺激於類風濕性關節炎的止痛和抗發炎療效研究,$200000,2019.8.1 ~ 2020.7.31
20﹒ 個別型,CMU107-TU-04,顏宏融(Hung-Rong Yen),宋瑛琪(Ying-Chyi Song)、林武周(Wu-Chou Lin)、劉良智(Liang-Chih Liu)、柯道維(Tao-Wei Ke),本校(含附醫),中藥對臨床癌症病人之免疫檢測及調控,$900000,2019.6.1 ~ 2020.7.31
21﹒ 個別型,採購案號:M08G1211,趙嶸(Chao, Jung),張永勳(Yuan-Shiun Chang)、顏宏融(Hung-Rong Yen)、黃世勳(Huang, Shyh-Shyun)、馬逸才(Yi-Cai Ma)、蔡邱轔(Chiu-Lin Tsai)、李威著,衛福部,108年度「臺灣中藥材炮製技術傳承計畫」,$2100000,2019.3.26 ~ 2019.12.15
22﹒ 個別型,MOHW108-CMAP-M-212-000103,黃升騰(Sheng-Teng Huang),孫茂峰(Mao-Feng Sun)、賴榮年(Jung-Nien Lai)、林嘉德(Chia-Der Lin)、邱德發(Te-Fa Chiu)、顏宏融(Hung-Rong Yen)、羅綸謙(Lun-Chien Lo)、張東?(Tung-Ti Chang)、林宏任(Hung-jen Lin)、李育臣(Yu-Chen Lee)、徐新政(Hsin-Cheng Hsu)、蘇珊玉(Shan-Yu Su)、黃國欽(Huang, Kuo-Chin)、林聖興(Sheng-Shing Lin)、黃敬軒(Ching-Hsuan Huang)、侯甫葦(Pu-Wei Hou)、蔡邱轔(Chiu-Lin Tsai)、吳旻峰(Min-Feng Wu)、涂慶業(Chin-Yeh Tu)、詹士賢(Shyh-Shyan Jan)、李雅玲(Ya-Ling Lee)、邱奕笙(Yi-Sheng Ciou)、陳暐棣(Wei-Di Chen)、洪瑞鴻(HUNG JUI-HUNG)、吳美瑤(Mei-Yao Wu)、何婧嫙(Ching-Hsuan Ho),衛福部,108年度「輔導中醫臨床技能評估模式及臨床教學實務訓練計畫」,$1450000,2019.1.25 ~ 2019.12.25
23﹒ 國家型,MOHW108-TDU-B-212-133004,許重義(Chung Y. Hsu),林昭庚(Jaung-Geng Lin)、蔡輔仁(Fuu-Jen Tsai)、林正介(Cheng-Chieh Lin)、趙坤山(Kun-San Chao)、陳明豐(Ming-Fong Chen)、周德陽(Der-Yang Cho)、張建國(Jan-Gowth Chang)、卓夙航(Suh-Hang Juo)、張恒鴻(Hen-Hong Chang)、江舟峰、藍先元(Hsien-Yuan Lane)、徐偉成(Woei-Cheang Shyu)、蘇冠賓(Kuan-Pin Su)、陳培君(PEI-CHUN CHEN)、陳怡文(Yi-Wen Chen)、蔡崇豪(Chon-Haw Tsai)、謝慶良(Ching-Liang Hsieh)、李采娟(Tsai-Chung Li)、白禮源(Li-Yuan Bai)、宋鴻樟(Fung-Chung J Sung)、周宜卿(I-Ching Chou)、葉士芃(Shih-Peng Yeh)、謝右文(Yow-Wen Hsieh)、劉崇祥(Chung-Hsiang Liu)、林嘉德(Chia-Der Lin)、洪士杰(Shih-Chieh Hung)、梁基安(Ji-An Liang)、顏宏融(Hung-Rong Yen)、孟乃欣(Nai-Hsin Meng)、黃秋錦(Chiu-Ching Huang)、王怡寬(I-Kuan Wang)、賴世偉(Lai, Shih-Wei)、張坤正(Kuan-Cheng Chang)、劉秋松(Chiu-Shong Liu)、溫啟邦(Chi-Pang Wen)、林志學(Chih-Hsueh Lin)、陳清助(Ching-Chu Chen)、高嘉鴻(Chia-Hung Kao)、蔡文正(Tsai, Wen-Chen)、余養豪、楊良友(Liang-Yo Yang)、溫永銳(Yeong-Ray Wen)、楊榮林(Rong-Lin Yang)、呂明桂(Ming-Kuei Lu)、林暉翰(Hui-Han Lin)、薛榮銀、田霓(Ni Tien),衛福部,精進臨床試驗能量及國際躍升計畫,$27584000,2019.1.1 ~ 2019.12.31
24﹒ 個別型,MOHW108-NRICM-M-124-000002,顏宏融(Hung-Rong Yen),吳曜充(Yao-Chung Wu)、陳盈佑(Ying-Yu Chen)、吳美瑤(Mei-Yao Wu),衛生福利部國家中醫藥研究所,常見中藥複方療效評估委託研究-乳癌患者接受中醫藥輔助治療的處方型態、存活分析、副作用緩解與安全性研究,$800000,2019.1.1 ~ 2019.12.31
25﹒ 整合型(召集人、總主持人),MOHW108-TDU-B-212-124024,趙坤山(Kun-San Chao),周德陽(Der-Yang Cho)、顏宏融(Hung-Rong Yen),衛福部,第3期癌症研究癌症中心計畫-創新醫療技術與中西整合醫療之癌症研究計畫(第二年),$12000000,2019.1.1 ~ 2019.12.31
26﹒ 個別型,MOST 105-2628-B-039-001-MY3,顏宏融(Hung-Rong Yen),科技部,毛蕊異黃酮對類風濕性關節炎的療效與免疫機轉研究,$1750000,2018.8.1 ~ 2019.7.31
27﹒ 個別型,MOST 107-2320-B-039-021-MY3,宋瑛琪(Song, Ying-Chyi),顏宏融(Yen, Hung-Rong),科技部,蟲草素在抑制樹突細胞及應用於治療多發性硬化症扮演的角色,$1200000,2018.8.1 ~ 2019.7.31
28﹒ 個別型,MOST 107-2314-B-039-037-,魏長菁(Chang-Ching Wei),顏宏融(Hung-Rong Yen)、吳伯元(Po-Yuan Wu),科技部,探討濕敷療法在中度異位性皮膚炎的兒童皮膚屏障功能的重建、皮膚微生物群落生物多樣性、疾病的嚴重度和生活品質的影響,$950000,2018.8.1 ~ 2019.7.31
29﹒ 個別型,案號:M07G1358,趙嶸(Chao, Jung),顏宏融(Hung-Rong Yen)、張永勳(Yuan-Shiun Chang)、黃世勳(Huang, Shyh-Shyun)、蔡邱轔(Chiu-Lin Tsai)、馬逸才、李威著,衛福部,107年度「台灣中藥炮製技藝傳承計畫」,$840000,2018.8.27 ~ 2018.12.15
30﹒ 個別型,DMR-108-004,顏宏融(Hung-Rong Yen),李佳玲(Chia-Ling Li),附醫院內計畫,毛蕊異黃酮對冷誘發纖維肌痛症作用與機轉,$103093,2018.8.1 ~ 2019.7.31
31﹒ 個別型,DMR-108-006,孫茂峰(Mao-Feng Sun),顏宏融(Hung-Rong Yen)、李佳玲,附醫院內計畫,多發性硬化症早期的認知缺陷,$300000,2018.8.1 ~ 2019.7.31
32﹒ 個別型,CMU107-ASIA-15,許游章(You-Cheng Hseu),顏宏融(Hung-Rong Yen),本校(含附醫),預防乾癬/紫外線誘導皮膚癌/皮膚光老化之分子機制探討,$480000,2018.8.1 ~ 2019.7.31
33﹒ 個別型,DMR-108-011,顏宏融(Hung-Rong Yen),劉傳騰,附醫院內計畫,以阻斷細胞激素 -17A協同抑制粒線體解偶聯蛋白 2 促進抗癌免疫力作為對抗胰臟癌的新穎策略,$200000,2018.8.1 ~ 2019.7.31
34﹒ 學生參與計畫,107-2813-C-039-277-B,郭丞婕(Cheng-Chieh Kuo),顏宏融(Hung-Rong Yen),科技部,丹參酮IIA誘導THP-1細胞產生細胞自噬與細胞凋亡的作用及機轉,$48000,2018.7.1 ~ 2019.2.28
35﹒ 個別型,MOHW107-CMAP-M-211-000103,孫茂峰(Sun, Mao-Feng),張恒鴻(Chang, Hen-Hong)、林嘉德(Lin, Chia-Der)、方信元(Fang, Hsin-Yuan)、黃升騰(Huang, Sheng-Teng)、顏宏融(Yen, Hung-Rong)、張東?(Chang, Tung-Ti)、林宏任(Lin, Hung-Jen)、李育臣(Lee, Yu-Chen)、徐新政(Hsu, Hsin-Cheng)、蘇珊玉(Su, Shan-Yu)、黃國欽(Huang, kuo-Chin)、林聖興(Lin, Sheng-Shing)、侯甫葦(Pu-Wei Ho)、蔡邱轔(Chiu-Lin Tsai),衛福部,107年度「輔導中醫臨床技能評估模式及臨床教學實務訓練計畫」,$1300000,2018.1.25 ~ 2018.12.15
36﹒ 國家型,MOHW107-TDU-B-212-123004,許重義(Hsu, Chung-Y.),林昭庚(Lin, Jaung-Geng)、蔡輔仁(Tsai, Fuu-Jen)、林正介(Lin, Cheng-Chieh)、趙坤山(Chao, Kun-San)、陳明豐(Chen, Ming-Fong)、周德陽(Cho, Der-Yang)、張建國(Chang, Jan-Gowth)、卓夙航(Juo, Suh-Hang)、張恒鴻(Chang, Hen-Hong)、薛榮銀、藍先元(Lane, Hsien-Yuan)、徐偉成(Shyu, Woei-Cherng)、蘇冠賓(Su, Kuan-Pin)、陳怡文(Chen, Yi-Wen)、謝慶良(Hsieh, Ching-Liang)、蔡崇豪(Tsai, Chon-Haw)、白禮源(Bai, Li-Yuan)、李采娟(Li, Tsai-Chung)、周宜卿(Chou, I-Ching)、宋鴻樟(Sung, Fung-Chang)、謝右文(Hsieh, Yow-Wen)、葉士芃(Yeh, Su-Peng)、林嘉德(Lin, Chia-Der)、劉崇祥(Liu, Chung-Hsiang)、梁基安(Liang, Ji-An)、洪士杰(Hung, Shih-Chieh)、孟乃欣(Meng, Nai-Hsin)、顏宏融(Yen, Hung-Rong)、王怡寬(Wang, I-Kuan)、黃秋錦(Huang, Chiu-Ching)、張坤正(Chang, Kuan-Cheng)、賴世偉(Lai, Shih-Wei)、溫啟邦(Wen, Chi-Pang)、劉秋松(Liu, Chiu-Shong)、陳清助(Chen, Ching-Chu)、林志學(Lin, Chih-Hsueh)、蔡文正(Tsai, Wen-Chen)、高嘉鴻(Kao, Chia-Hung)、楊良友(Yang, Liang-Yo)、余養豪(Yu, Yang-Hao)、楊榮林(Yang, Rong-Lin)、溫永銳(Wen, Yeong-Ray)、林暉翰(Hui-Han Lin)、呂明桂(Lu, Ming-Kuei)、田霓(Tien, Ni),衛福部,精進臨床試驗能量及國際躍升計畫,$29257000,2018.1.1 ~ 2018.12.31
37﹒ 整合型(召集人、總主持人),MOHW107-TDU-B-212-114024,趙坤山(Chao, Kun-San),周德陽(Cho, Der-Yang)、顏宏融(Yen, Hung-Rong),衛福部,第3期癌症研究癌症中心計畫-創新醫療技術與中西整合醫療之癌症研究計畫,$12000000,2018.1.1 ~ 2018.12.31
38﹒ 國家型,MOHW107-CMAP-M-114-122109,顏宏融(Hung-Rong Yen),賴琬郁(Wan-Yu Lai)、魏長菁(Chang-Ching Wei)、王清源(Ching-Yuan Wang)、林建亨(Chien-Heng Lin)、楊佩珊(Yang pei shan)、吳美瑤(Mei-Yao Wu),衛福部,107年度「促進中醫多元發展計畫」,分項1:建構中西醫合作照護模式計畫,$945000,2018.1.1 ~ 2018.12.15
39﹒ 國家型,CMRC-CHM-0,顏宏融(Hung-Rong Yen),黃升騰(Sheng-Teng Huang)、李家琳(Chia-Lin Lee)、林振文(Lin Cheng Wen)、趙嶸(Chao, Jung)、湯智昕(Chih-Hsin Tang)、謝文聰、郭悅雄(Yueh-Hsiung Kuo)、郭盛助(Sheng-Chu kuo)、王陸海(Liu-Hai Wang)、佘玉萍(Yuh-Pyng Sher)、許游章(You-Cheng Hseu)、高銘欽(Ming-Ching Kao),教育部,中醫藥研究中心-中草藥研究群組,$10200000,2018.1.1 ~ 2018.12.31
40﹒ 個別型,MOST 104-2320-B-039-026-MY3,孫茂峰(SUN, MAO-FENG),周立偉(Li-Wei Chou)、顏宏融(Hung-Rong Yen)、葉月嬌,科技部,中藥補骨脂對類風濕性關節炎的療效與機轉研究,$1500000,2017.8.1 ~ 2018.7.31
41﹒ 個別型,MOST 105-2628-B-039-001-MY3,顏宏融(Hung-Rong Yen),科技部,毛蕊異黃酮對類風濕性關節炎的療效與免疫機轉研究,$1700000,2017.8.1 ~ 2018.7.31
42﹒ 個別型,DMR-107-149,廖元敬(Yuan-Ching Liao),顏宏融(Yen, Hung-Rong)、黃國欽(Huang, kuo-Chin)、林宏任(Lin, Hung-Jen),附醫院內計畫,糖尿病腎病變蛋白尿:單一醫學中心之回溯性觀察研究,$465000,2017.8.1 ~ 2018.7.31
43﹒ 個別型,DMR-107-004,孫茂峰(Sun, Mao-Feng),顏宏融(Yen, Hung-Rong),附醫院內計畫,電針或經皮神經電刺激對於緩解產後早期乳房腫脹之附加效用比較–實用性隨機預試驗,$500000,2017.8.1 ~ 2018.7.31
44﹒ 個別型,DMR-107-154,林怡君(Yi-Chun Lin),顏宏融(Yen, Hung-Rong)、蔡輔仁(Tsai, Fuu-Jen)、王仲興(Chung-Hsing Wang)、陳安琪(Chen, An-Chyi),附醫院內計畫,兒童生長遲緩: 單一醫學中心之回溯性觀察研究,$400000,2017.8.1 ~ 2018.6.30
45﹒ 個別型,DMR-107-009,賴琬郁(Wan-Yu Lai),顏宏融(Yen, Hung-Rong)、魏長菁(Wei , Chang-Ching),附醫院內計畫,中西醫合作照護治療兒童持續、中重度過敏性鼻炎併發睡眠障礙之成效評估,$300000,2017.8.1 ~ 2018.7.31
46﹒ 個別型,MOST 106-2320-B-039-036-,宋瑛琪(Song, Ying-Chyi),顏宏融(Yen, Hung-Rong),科技部,白花蛇舌草誘發專一性抗腫瘤反應的效用及機制,$1333000,2017.8.1 ~ 2018.7.31
47﹒ 個別型,DMR-107-005,顏宏融(Yen, Hung-Rong),附醫院內計畫,塵螨誘導發炎體活化與類固醇治療抗性之研究,$300000,2017.8.1 ~ 2018.7.31
48﹒ 個別型,MOHW106-CMAP-M-211-000103,孫茂峰(SUN, MAO-FENG),張恒鴻(CHANG,HEN-HONG)、林嘉德(Chia-Der Lin)、方信元(Hsin-Yuan Fang)、黃升騰(Huang, Sheng-Teng)、顏宏融(Hung-Rong Yen)、張東?(Tung-Ti Chang)、林宏任(Lin Hung-jen)、李育臣(Yu-Chen Lee)、徐新政(Hsin-Cheng Hsu)、蘇珊玉(Shan-Yu Su)、黃國欽(kuo-Chin Huang)、侯甫葦(Pu-Wei Ho)、蔡邱轔(Chiu-Lin Tsai)、何婧嫙(Ching-Hsuan Ho),衛福部,輔導中醫臨床技能評估模式及教學實務訓練計畫,$1450000,2017.1.9 ~ 2017.12.15
49﹒ 個別型,CHM106-4,顏宏融(Hung-Rong Yen),宋瑛琪(Ying-Chyi Song)、黃慧琪(Hui-Chi Huang),教育部,中醫藥研究中心(中草藥研究群組),白花蛇舌草於癌症免疫療法之研發,$900000,2017.1.1 ~ 2017.12.31
50﹒ 國家型,M0HW106-CMAP-M-114-112105,顏宏融(Hung-Rong Yen),魏長菁(Chang-Ching Wei)、鄭慧滿(Hui-Man Cheng)、吳伯元(Wu, Po-Yuan)、賴琬郁(Wan-Yu Lai)、楊佩珊(Pei-Shan Yang),衛福部,106年度「促進中醫多元發展計畫」,分項1:建構中西醫合作照護模式計畫,$920000,2017.1.17 ~ 2017.12.15
51﹒ 國家型,NA,顏宏融(Hung-Rong Yen),謝慶良(Ching-Liang Hsieh)、林以文(Lin, Yi-Wen)、蘇冠賓(Kuan-Pin Su)、溫永銳(Yeong-Ray Wen)、陳易宏、李家琳(Chia-Lin Lee)、郭盛助(Sheng-Chu kuo)、佘玉萍(Yuh-Pyng Sher)、郭悅雄(Yueh-Hsiung Kuo)、許游章(You-Cheng Hseu)、林振文(Lin Cheng Wen)、黃升騰(Sheng-Teng Huang)、謝文聰、高銘欽(Ming-Ching Kao)、高尚德(Shung-Te Kao),教育部,中醫藥研究中心,$32354170,2017.1.1 ~ 2017.12.31
52﹒ 整合型(召集人、總主持人),CMU105-BC-1-1,顏宏融(Hung-Rong Yen),本校(含附醫),中醫藥治療進行性全身硬化症的效與機轉研究,$500000,2016.10.19 ~ 2017.7.31
53﹒ 個別型,MOST 104-2320-B-039-026-MY3,孫茂峰(SUN, MAO-FENG),周立偉(Li-Wei Chou)、顏宏融(Hung-Rong Yen)、葉月嬌,科技部,中藥補骨脂對類風濕性關節炎的療效與機轉研究,$1440000,2016.8.1 ~ 2017.7.31
54﹒ 個別型,MOST 105-2320-B-039-027-,李育臣(Yu-Chen Lee),顏宏融(Hung-Rong Yen)、蘇冠賓(Kuan-Pin Su)、孫茂峰(SUN, MAO-FENG)、杜政昊(Cheng-Hao Tu),科技部,針灸療法之神經、心理及生物效應研究:以針灸療法探討憂鬱症之身心介面,$900000,2016.8.1 ~ 2017.7.31
55﹒ 個別型,MOST 105-2628-B-039-001-MY3,顏宏融(Hung-Rong Yen),科技部,毛蕊異黃酮對類風濕性關節炎的療效與免疫機轉研究,$1650000,2016.8.1 ~ 2017.7.31
56﹒ 個別型,105-2320-B-039-005-,宋瑛琪(Ying-Chyi Song),顏宏融(Hung-Rong Yen),科技部,傳統中藥對於治療鼻咽癌的免疫反應及分子機制,$1000000,2016.8.1 ~ 2017.7.31
57﹒ 個別型,DMR-106-158,賴琬郁(Wan-Yu Lai),顏宏融(Hung-Rong Yen)、魏長菁(Chang-Ching Wei),附醫院內計畫,中文版SN-5兒童鼻及鼻竇炎生活品質良表的信度與效度,以及兒童鼻及鼻竇疾病與兒童阻塞性睡眠呼吸中止症和氣喘相關性研究探討。,$300000,2016.8.1 ~ 2017.6.30
58﹒ 個別型,MOST 105-2320-B-039-005-,宋瑛琪(Ying-Chyi Song),張恒鴻(CHANG,HEN-HONG)、顏宏融(Hung-Rong Yen)、劉士任(Shih-Jen Liu),科技部,傳統中藥對於治療鼻咽癌的免疫反應及分子機制,$1000000,2016.8.1 ~ 2017.7.31
59﹒ 學生參與計畫,105-2815-C-039-012-B,顏宏融(Hung-Rong Yen),科技部,中藥調控免疫檢查點PD-1在癌症免疫療法之研究,$48000,2016.7.1 ~ 2017.2.28
60﹒ 國家型,MOHW105-NRICM-C-104-122-001,謝慶良(Ching-Liang Hsieh),蔡崇豪(Chon-Haw Tsai)、黃偉師(Wei-Shih Huang)、劉崇祥(Chung-Hsiang Liu)、呂明桂(Ming-Kuei Lu)、徐偉成(Woei-Cherng Shyu)、楊玉婉(Yu-Wan Yang)、曾鈞宏(Chun-Hung Tseng)、黃匯淳(Hui-Chun Huang)、許怡婷(Yi-Ting Hsu(Hseu))、周立偉(Li-Wei Chou)、郭育呈(Yuh-Cherng Guo)、林昭庚(Jaung-Geng Lin)、李采娟(Tsai-Chung Li)、顏宏融(Hung-Rong Yen)、陳睿正(Jui-Cheng Chen)、陳冠妃(Kuan-Fei Chen)、賴仲亮(Chung-Liang Lai),衛福部,「中藥品質及中醫藥輔助療效研究」計畫-後續擴充105年,$1317000,2016.4.1 ~ 2017.3.31
61﹒ 個別型,MOHW105-CMAP-M-211-000104,孫茂峰(SUN, MAO-FENG),張恒鴻(CHANG,HEN-HONG)、林嘉德(Chia-Der Lin)、方信元(Hsin-Yuan Fang)、顏宏融(Hung-Rong Yen)、蔡真真、陳建仲、彭昱憲、張東?(Tung-Ti Chang)、林宏任(Lin Hung-jen)、李育臣(Yu-Chen Lee)、楊中賢(Chung-Hsion Yang)、徐新政(Hsin-Cheng Hsu)、蘇珊玉(Shan-Yu Su)、黃國欽(kuo-Chin Huang)、蔡邱轔(Chiu-Lin Tsai),,105年度「建置中醫臨床技能測驗中心計畫」,$1132500,2016.2.29 ~ 2016.12.15
62﹒ 個別型,採購案號:M05G9040,顏宏融(Hung-Rong Yen),黃秋錦(Chiu-Ching Huang)、孫茂峰(SUN, MAO-FENG)、張志宗(Chiz-Tzung Chang)、黃升騰(Huang, Sheng-Teng)、王怡寬(I-Kuan Wang)、黃國欽(kuo-Chin Huang)、郭慧亮(Huey-Liang kuo)、林宏任(Lin Hung-jen)、劉耀隆(Yao-Lung Liu)、李育臣(Yu-Chen Lee)、周哲毅(Che-Yi Chou)、丁羿文(I-Wen Ting)、楊雅斐(Ya-Fei Yang)、廖元敬(Yuan-Ching Liao)、李艾玲(Ai-Lin Lee)、楊潤(Jun Yang),衛福部,105年度「促進中醫多元發展」委託科技研究計劃,分項3:建構中醫日間照護模式計畫,$900000,2016.1.19 ~ 2016.12.15
63﹒ 國家型,10543TU6,顏宏融(Hung-Rong Yen),教育部,中醫藥研究中心(中草藥研究群組):子題2.6青黛軟膏新藥之研發,$500000,2016.1.1 ~ 2016.12.31
64﹒ 國家型,NA,顏宏融(Hung-Rong Yen),孫茂峰(SUN, MAO-FENG)、李育臣(Yu-Chen Lee)、李采娟(Tsai-Chung Li)、陳俊宏(Jiunn-Horng Chen)、黃明正(Ming-cheng Huang),教育部,中醫藥研究中心(中醫暨針灸研究群組): 針灸治療纖維肌痛症之臨床轉譯研究,$240000,2016.1.1 ~ 2016.12.31
65﹒ 個別型,MOHW105-CMAP-M114-122403,林香汶(Margaret Hsiang-Wen Lin),林聖興(Sheng-Shing Lin)、顏宏融(Hung-Rong Yen)、張東?(Tung-Ti Chang)、周哲毅(Che-Yi Chou)、蔡馨慧(Hsin-Hui Tsai)、蔡邱轔(Chiu-Lin Tsai)、李采娟(Tsai-Chung Li)、李佳霙(Chia-Ing Li)、張淑貞(Shu-Jen Chang)、黃世勳(Huang, Shyh-Shyun),衛福部,中藥使用風險管理模式研究,$1250000,2016.1.1 ~ 2016.12.15
66﹒ 個別型,NSC 102-2320-B-039-057-MY3,顏宏融(Hung-Rong Yen),科技部,中藥紫檀氏調節CD4 TH17免疫力與自體免疫疾病的功能與機轉研究,$1250000,2015.8.1 ~ 2016.7.31
67﹒ 個別型,MOST 104-2320-B-039-026-MY3,孫茂峰(SUN, MAO-FENG),周立偉(Li-Wei Chou)、顏宏融(Hung-Rong Yen)、葉月嬌,科技部,中藥補骨脂對類風濕性關節炎的療效與機轉研究,$1450000,2015.8.1 ~ 2016.7.31
68﹒ 個別型,DMR-105-003,孫茂峰(SUN, MAO-FENG),顏宏融(Hung-Rong Yen),附醫院內計畫,當歸拈痛湯對類風濕性關節炎的療效與機轉研究,$400000,2015.8.1 ~ 2016.7.31
69﹒ 國家型,MOHW104-NRICM-C-104-112-001,謝慶良(Ching-Liang Hsieh),蔡崇豪(Chon-Haw Tsai)、黃偉師(Wei-Shih Huang)、劉崇祥(Chung-Hsiang Liu)、呂明桂(Ming-Kuei Lu)、徐偉成(Woei-Cherng Shyu)、楊玉婉(Yu-Wan Yang)、曾鈞宏(Chun-Hung Tseng)、黃匯淳(Hui-Chun Huang)、許怡婷(Yi-Ting Hsu(Hseu))、周立偉(Li-Wei Chou)、郭育呈(Yuh-Cherng Guo)、林昭庚(Jaung-Geng Lin)、李采娟(Tsai-Chung Li)、顏宏融(Hung-Rong Yen)、陳睿正(Jui-Cheng Chen)、陳冠妃(Kuan-Fei Chen),衛福部,104年度「中藥品質及中醫藥輔助療效研究」計畫,$1500000,2015.4.1 ~ 2016.3.31
70﹒ 個別型,MOHW104-CMAP-M-114-112412,林香汶(Margaret Hsiang-Wen Lin),林聖興(Sheng-Shing Lin)、顏宏融(Hung-Rong Yen)、張東?(Tung-Ti Chang)、周哲毅(Che-Yi Chou)、蔡馨慧、蔡邱轔(Chiu-Lin Tsai)、李采娟(Tsai-Chung Li)、李佳霙(Chia-Ing Li)、張淑貞(Shu-Jen Chang)、黃世勳(Huang, Shyh-Shyun),衛福部,中藥使用與風險管理模式研究,$1200000,2015.3.20 ~ 2015.12.15
71﹒ 個別型,案號:M04G9050,顏宏融(Hung-Rong Yen),孫茂峰(SUN, MAO-FENG)、張恒鴻(CHANG,HEN-HONG)、楊中賢(Chung-Hsion Yang)、張東?(Tung-Ti Chang)、林宏任(Lin Hung-jen)、李育臣(Yu-Chen Lee)、徐新政(Hsin-Cheng Hsu)、黃秋錦(Chiu-Ching Huang)、張志宗(Chiz-Tzung Chang)、劉炯勳(Jiung-Hsiun Liu)、周哲毅(Che-Yi Chou)、陳虹志(Hung-Chih Chen)、蘇珊玉(Shan-Yu Su),衛福部,104年度「改善中醫臨床訓練環境計畫」案,分項計畫3:建構中醫日間照護模式計畫,$930000,2015.2.6 ~ 2015.12.15
72﹒ 個別型,NHRI-EX104-10124SC,顏宏融(Hung-Rong Yen),國衛院,第十七型CD8 T 細胞(Tc17):研究其功能可塑性與免疫治療之應用,$1266000,2015.1.1 ~ 2015.12.31
73﹒ 整合型項下子計畫(主持人),NA,顏宏融(Hung-Rong Yen),陳俊宏、孫茂峰(SUN, MAO-FENG)、李育臣(Yu-Chen Lee)、李采娟(Tsai-Chung Li)、黃明正(Ming-cheng Huang),教育部,中醫藥研究中心(中醫暨針灸研究群組),B-2:針灸治療纖維肌痛症之臨床轉譯研究,$250000,2015.1.1 ~ 2015.12.31
74﹒ 國家型,2-5,顏宏融(Hung-Rong Yen),教育部,中醫藥研究中心(中草藥研究群組),$754033,2015.1.1 ~ 2015.12.31
75﹒ 整合型項下子計畫(主持人),CMU103-BC-4-2,顏宏融(Hung-Rong Yen),江耀璋(Yao-Chang Chiang),本校(含附醫),針灸對憂鬱症患者的神經發炎免疫指標之影響,$800000,2014.10.14 ~ 2015.7.31
76﹒ 個別型,NSC 102-2320-B-039-057-MY3,顏宏融(Hung-Rong Yen),科技部,中藥紫檀氏調節CD4 TH17免疫力與自體免疫疾病的功能與機轉研究,$1250000,2014.8.1 ~ 2015.7.31
77﹒ 個別型,NSC 101-2314-B-182-014-MY3,林奏延,張仕政、顏宏融(Hung-Rong Yen)、黃冠穎,科技部,幼兒對流感病毒疫苗之體液與細胞免疫反應,$1300000,2014.8.1 ~ 2015.7.31
78﹒ 個別型,DMR-104-003,孫茂峰(SUN, MAO-FENG),顏宏融(Hung-Rong Yen),附醫院內計畫,探討補骨脂對類風濕性關節炎的療效,$300000,2014.8.1 ~ 2015.7.31
79﹒ 國家型,NRICM103-CR-01,謝慶良(Ching-Liang Hsieh),蔡崇豪(Chon-Haw Tsai)、黃偉師(Wei-Shih Huang)、劉崇祥(Chung-Hsiang Liu)、呂明桂(Ming-Kuei Lu)、徐偉成(Woei-Cherng Shyu)、楊玉婉(Yu-Wan Yang)、曾鈞宏(Chun-Hung Tseng)、黃匯淳(Hui-Chun Huang)、許怡婷(Yi-Ting Hsu(Hseu))、周立偉(Li-Wei Chou)、郭育呈(Yuh-Cherng Guo)、林昭庚(Jaung-Geng Lin)、李采娟(Tsai-Chung Li)、顏宏融(Hung-Rong Yen),衛福部,103年度中醫藥轉譯計畫「中藥複方輔助治療缺血型中風臨床療效評估委託研究計畫」,$1518000,2014.4.24 ~ 2015.3.31
80﹒ 校內其他單位控管計畫(例如:教卓計畫),NA,吳永昌(Yang-Chang Wu),郭盛助(Sheng-Chu Kuo)、林欣榮(Shinn-Zong Lin)、韓鴻志(Horng-Jyh Harn)、張建國(Jan-Gowth Chang)、林振文(Lin Cheng Wen)、湯智昕(Tang Chih-Hsin)、郭悅雄(Yueh-Hsiung Kuo)、陳悅生(Yueh-Sheng Chen)、林文川(Wen-Chuan Lin)、陳珠璜(Chu-Huang Chen)、林應如(Ying-Ju Lin)、侯庭鏞(Tin-Yun Ho)、顏宏融(Hung-Rong Yen),教育部,中醫藥研究中心(中草藥研究群組),$17100000,2014.4.1 ~ 2014.12.31
81﹒ 個別型,A-3-2-A,張志宗(Chiz-Tzung Chang),顏宏融(Hung-Rong Yen)、孫茂峰(SUN, MAO-FENG)、李育臣(Yu-Chen Lee)、陳虹志(Hung-Chih Chen)、李采娟(Tsai-Chung Li),教育部,中醫藥研究中心(中醫暨針灸研究群組),$406708,2014.4.1 ~ 2014.12.31
82﹒ 個別型,A-1-2-A,顏宏融(Hung-Rong Yen),陳俊宏(Jiunn-Horng Chen)、孫茂峰(SUN, MAO-FENG)、李育臣(Yu-Chen Lee)、李采娟(Tsai-Chung Li)、黃明正(Ming-cheng Huang),教育部,中醫藥研究中心(中醫暨針灸研究群組)(針灸治療纖維肌痛症之臨床療效研究:單一中心、隨機、評估者與受試者雙盲、對照、平行設計臨床試驗),$197000,2014.4.1 ~ 2014.12.31
83﹒ 個別型,NHRI-EX103-10124SC,顏宏融(Hung-Rong Yen),林俊彥(Chun-Yen Lin)、黃景泰(Ching-Tai Huang)、林永昌(Yung-Chang Lin),國衛院,第十七型CD8 T 細胞(Tc17):研究其功能可塑性與免疫治療之應用,$1061000,2014.1.1 ~ 2014.12.31
84﹒ 個別型,NSC 102-2320-B-039-057-MY3,顏宏融(Hung-Rong Yen),科技部,中藥紫檀氏調節CD4 TH17免疫力與自體免疫疾病的功能與機轉研究,$1238858,2013.9.1 ~ 2014.7.31
85﹒ 個別型,NHRI-EX102-10124SC,顏宏融(Hung-Rong Yen),國衛院,第十七型CD8 T 細胞(Tc17):研究其功能可塑性與免疫治療之應用,$88440,2013.9.1 ~ 2013.12.31
86﹒ 個別型,DMR-103-123,顏宏融(Hung-Rong Yen),張東?(Tung-Ti Chang),附醫院內計畫,中醫藥調節CD4 TH17 免疫力的研究:建立體外細胞篩選平台與體內小鼠疾病模型的療效研究,$300000,2013.8.1 ~ 2014.6.30
87﹒ 個別型,NSC 101-2314-B-182-014-MY3,林奏延(Tzou-Yien Lin),張仕政、顏宏融(Hung-Rong Yen)、黃冠穎,科技部,幼兒對流感病毒疫苗之體液與細胞免疫反應,$1300000,2013.8.1 ~ 2014.7.31
88﹒ 個別型,NSC 101-2314-B-182-014-MY3,林奏延(Tzou-Yien Lin),張仕政、顏宏融(Hung-Rong Yen)、黃冠穎,國衛院,幼兒對流感病毒疫苗之體液與細胞免疫反應,$1300000,2012.8.1 ~ 2013.7.31
89﹒ 個別型,NHRI-EX101-10124SC,顏宏融(Hung-Rong Yen),黃景泰(Ching-Tai Huang)、林俊彥(Chun-Yen Lin)、林永昌(Yung-Chang Lin),國衛院,第十七型CD8 T 細胞(Tc17):研究其功能可塑性與免疫治療之應用,$1970000,2012.1.1 ~ 2012.12.31
 
獲獎/Award
(獲獎名稱,給獎單位,獲獎日期)
1﹒ 107年度推動台灣中醫國際化貢獻獎 貢獻殊偉,中華民國中醫師公會全國聯合會,2018.11.04
2﹒ Distinquished Invited Speech,UNESCO (聯合國教科文組織),2018.11.17
3﹒ 中國醫藥大學附設醫院107年度傑出醫師,本校(含附醫),2018.11.16
4﹒ 第19屆國際東洋醫學學術大會壁報論文獎,中華民國中醫師公會全國聯合會、Taiwan Chinese Medical Association (TCMA)、中國醫藥大學,2018.11.26
5﹒ 106年度優良教師專業社群「中醫英文臨床教學專業社群」,中國醫藥大學教師發展中心,2018.03.13
6﹒ 105學年度中國醫藥大學「副教授級」傑出教授當選人,中國醫藥大學教師發展中心,2017.12.29
7﹒ 105年度優良教師專業社群「中醫英文臨床教學專業社群」,中國醫藥大學教師發展中心,2017.05.10
8﹒ 2017 AAI Laboratory Travel Grant,美國免疫學者學會(The American Association of Immunologists),2017.05.12
9﹒ AAI Travel Grant for the International Congress of Immunology 2016 (ICI 2016),美國免疫學者學會(The American Association of Immunologists),2016.08.21
10﹒ 中國醫藥大學附設醫院103年度傑出主治醫師(Elite Physician)名單,本校(含附醫),2014.10.16